Sei sulla pagina 1di 60

2011KPMG,anIndianPartnershipandamemberfirmoftheKPMGnetworkofindependentmemberfirmsaffiliatedwithKPMGInternationalCooperative(KPMGInternational),aSwissentity.Allrightsreserved.

Acknowledgement
Indias competitive advantage lies in the lower production and research cost, its large
pool of low cost technical and scientifically trained personnel, and large number of
compliance certified manufacturers and serviceproviders, which make us different from
others. ASSOCHAM feels that technology incubation is no longer confined to a few
institutions; it is a responsibility that wehave to share, if we wish to see a better and a
healthy future ahead. There is an immense need to develop skilled manpower in the
area of healthcare and modern as well as traditional medicines. I am glad that
thisSummit on Emerging trends in Healthcare will bring forth the journey from research
desk to the bedside of patient, as we will look at healthcare at the frontline to identify
some common challenges that may help explain the complex nature of healthcare and
the scale of the change challenge.
I wish to thank KPMG for unanimously contributing towards this Knowledge Paper,
which gives a rich and comprehensive insight of the trend in healthcare. I would also
take the opportunity to thank QCI for supporting this event. The case studies contributed
providing the best of their services and support towards improving the healthcare
scenario of India, I wish them great success ahead. Last but not the least, I wish to
extend a token of appreciation for the Healthcare/ BioPharma team for their effort and
interaction with the Healthcare/Bio Pharma industry at different levels.
(D.S. Rawat)
Secretary General
ASSOCHAM

Acknowledge

ent

Indiascompetitive advantagelies in the


lowerproductionandresearchcost, itslargepool of low
costtechnicalandscientificallytrainedpersonnel,andlargenumberofco
mpliance
c rtifiedmanufacturersandserviceproviders,whichmakeus
different fr m others.ASSOCHAMfeelsthat technology
incubation is nolongerconfined to a fewinstitutions;it is a
respo sibility that we have to share, if we wish to see a better
and a healthyfutureahead.There is animmenseneed
todevelopskilledmanpowerintheareaofhealthcareand
modernaswellastraditionalmedicines. I am gladthatthisSummiton
Emrgingtrends in Healthcarewillbringforththejourneyfrom
researchdesk to th
bedsideofpatient,as wewilllookat
heathcareatthefrontline
to
identifysomecommonchallengesthatmayhelpexplainthe
complexnature of healthcareandthescaleofthechangechallenge.
I wish to
thankKPMGforunanimouslycontributingtowardsthisKnowledgePape
r,whichgives a rich andcomprehensiveinsight
ofthe tren inhe lthcare. I wouldalsotaketheopportunity to
thankQCI fo supportingthisevent.Thecasestudies
c ntributedbythedynamicstakeholdersshow theirvibrant
effortsand c mmitmenttowardsproviding the bestof their
srvices a d supporttowardsimprovingthehealthcarescenario
ofIndia, I wish th m greatsuccessahead.Lastbutnottheleast,
I wish to extend a tokenofappreciation for theHealthcare/
Bio harma t am fortheireffortandinteractionwiththe
Healthcare/Bio P armaindustryat differentlevels.

(D.S.Rawat)Secretary
GeneralASSOCHAM

Contents

Introduction

Changing disease patterns: Implication for healthcare infrastructure

Emerging Trends in Healthcare Delivery

10

Building Functional Efficiencies

21

Conclusion

25

CaseStudies
1. Acuity Information Systems Pvt. Ltd. (AcuVena)

29

2. Arogya Parivar (Novartis)

32

3. Chronic Care Foundation

34

4. Fresenius Medical Care India

36

5. Shantha Biotechnics

38

6. VLCC

40

Introduction
The Healthcare sector, in India, is at an inflection point and is poised
for rapid growth in the medium term. However, Indian healthcare
expenditure is still amongst the lowest globally and there are
significant challenges to be addressed both in terms of accessibility of
healthcare service and quality of patient care. While this represents
significant opportunity for the private sector, the Government can also
play an important role in facilitating this evolution.
Current State of Healthcare in India
Current Size of the Healthcare Industry
1

TheIndianHealthcaresectorcurrentlyrepresentsaUSD40Billionindustry .Abreak-upofthesectorasof 2009 is


provided:
HealthcareIndustryBreak-up
Insurance&
MedicalEqui
pment15%

Diagnostics
10%

Hospital
50%

Pharma25
%

Source: IDFC Securities Hospital Sector November 2010


Indiashealthcarespendissignificantlylowwhencomparedtotheglobal,developedandothersimilaremergingecon
omies.Tofurtherillustratethispoint,wehaveexaminedtheIndianhealthcarespendonvarious parameters.
TheIndianhealthcarespendislessthanhalfthe globalaverageinpercentagetermswhencomparedon apercent
of GDP basis.

Source: IBEF
1

Spendingasa%ofGDP
18.00%
15.70%
14.00%
12.00%
9.70%

10.00%

8.40%

8.40%

8.00%
6.00%
4.30%

4.10%

4.00%
2.00%
0.00%
China

Brazil

India

USA

UK

Global

Source: WHO World Health Statistics 2010


Thehealthcarespend,whencomparedonthebasisofpublicprivatecontribution,alsodepictsaskewedpicture.Asisnotedfromthecomparisonbelow,PrivateSectorcontribution
tothehealthcaresectorat~75percentisamongstthehighestintheworldinpercentageterms.Publicspending,onthe
otherhand,isamongst the lowest in the world and is ~23 percentage points lower than the global average.
Comparisonof HealthcareSpend
90.00%

81.70%

80.00%

73.80%

70.00%
60.00%
50.00%

55.30%
44.70%

58.40%

45.50%

41.60%

40.00%

59.60%

54.50%

40.40%
26.20%

30.00%

18.30%

20.00%
10.00%
0.00%

China

Brazil

India

USA

UK

Global

PublicSectorspending PrivateSectorSpending

Source: WHO World Health Statistics 2010


Finally,thehealthcarespendexaminedonapercapitabasis,bothintermsofUSD(ataverageexchangerateconversi
on)andintermsofPurchasingPowerParity(PPP),isamongstthelowestglobally.Further,whencomparedtotheglob
alaverage,thepercapitaIndianhealthcarespendis~95percentloweronanaverage exchange rate basis and ~87
percent lower on a PPP basis.

PerCapitaSpending(US$)
8,000
7,285
7,000
6,000
5,000
3,867
4,000
3,000
2,000
802

606

1,000
108

40

China

Brazil

India

USA

UK

Global

Source: WHO World Health Statistics 2010

PerCapitaSpending(PPP)
8,000

7,285

7,000
6,000
5,000

4,000

2,992

3,000
2,000
1,000

863

837
233

109

China

Brazil

India

USA

UK

Global

Source: WHO World Health Statistics 2010


Indiashealthcarespendingis,however,growingatahealthyCAGRof~14percentfrom5.5percentoftheGDPin200
9to 8 percentin2012.

Growth in the Healthcare Industry


Asstatedearlier,theIndianHealthcareIndustryiscurrentlyestimatedatUSD40Billion.Theindustryisexpectedtogro
3

wto~USD79Billionby2012and~USD280Billionby2020 .TheaverageCAGRforthenext 10 years, therefore, has


been estimated at ~ 21 percent.

IBEF November 2010


IBEF_November 2010

HealthcareIndustry
300

280

250

200
CA G R 21%

150
100

79
40

50

0
2010

2012E

2020P

Source: IBEF

Drivers of growth for the Healthcare Sector


AcombinationofdemographicandeconomicfactorsisexpectedtobringaboutincreasedhealthcarecoverageinIndi
awhichisexpectedtodrive the growth of the sector
Demographic factors:

IncreaseinPopulation:Expectedincreaseinpopulationfromabout1.1billionin20094
2010to1.4billionby2026

Shiftindemographics:60percentofthepopulationintheyoungeragebracketandanexpectedincreaseofgeri
atricpopulationfromcurrent96milliontoaround168millionby2026.Thisrepresentsa huge patient base and
5

creates a market for preventive, curative and geriatric care opportunities


Riseindisposableincome:HouseholdsintheaboveINR200,000perannumbracketcanbenefitfromanincre
aseindisposableincomefrom14percentin2009-2010Eto26percentin2014-2015Pmaking healthcare more
affordable

Increaseinincidenceoflifestylerelateddiseases:Thereislikelytobeamarkedincreaseintheincidenceoflifestylerelateddiseases,suchascardiovascular,oncologyanddiabetes,whencomparedtothecommunicableandinf
ectiousdiseases
RisingLiteracy:Growinggeneralawareness,patientpreferencesandbetterutilisationofinstitutionalised
7
care as a result of increase in literacy rates

Economic factors:

Taxbenefits:Lowerdirecttaxes,higherdepreciationonmedicalequipment,incometaxexemptionfor 5 years
8
to hospitals in rural areas, etc. are being provided by the Government to the sector

MedicalTourism:Indiaemergingasamajormedicaltouristdestinationwithmedicaltourismmarketexpected
9
to reach USD 2 billion by 2012

Crisil Research Hospitals Annual Review November 2010


KPMG Analysis
6
Crisil Research Hospitals Annual Review November 2010
7
NFHS Survey
8
KPMG Analysis
9
IDFC Securities Hospital Sector November 2010
5

Insurancecoverage:Increaseinhealthinsurancecoveragewithanumberofprivateplayersandforeignplayer
senteringthemarkettocatertoincreaseddemand.Thesectorisexpectedtoseeandincreaseinthepenetrationfr
omthecurrent10percent15percenttoalmost50percentataCAGRof24percent.Ataninstitutionallevel,insurancepenetrationislikelyto
continuetoincreasefrom5percentto15percentto20percent.Intertiarycarethisisalmostashighas40percent10
55percentwith the inclusion of employer paid coverage.

Emerging Trends in Healthcare: Challenges and Interventions

WhiletheIndianHealthcaresectorispoisedforgrowthinthenextdecade,itisstillplaguedbyvariousissues
challenges:
Dual Disease Burden:

and

UrbanIndiaisnowonthethresholdofbecomingthediseasecapitaloftheworldandfacinganincreasedincide

nceofLifestylerelateddiseasessuchascardiovasculardiseases,diabetes,cancer,COPDetc.Atthesameti
me,theUrbanPoorandRuralIndiaarestrugglingwithCommunicableDiseasessuchastuberculosis,typhoi
d,dysenteryetc.RuralIndiaisalsoseeingahigheroccurrenceofNon-CommunicableLifestylerelateddiseases.ThisrepresentsaseriouschallengethattheIndianHealthcare system would need
to address
LackofInfrastructureandManpower:Accessibilitytohealthcareservicesisextremelylimitedtomanyruralar
easofthecountry.Inaddition,existinghealthcareinfrastructureisunplannedandisirregularlydistributed.Furthe
r,thereisaseverelackoftraineddoctorsandnursestoservicetheneeds of the large Indian populous.

Theprivatesectorhasevolvedamultiprongedapproachtoincreaseaccessibilityandpenetration.IthastackledtheissueofLifestylerelateddiseaseswitht
hedevelopmentofhigh-endtertiarycarefacilities.AlsonewdeliverymodelssuchasDaycarecentres,singlespecialtyhospitals,end-oflifecarecentres,etc.areonthehorizontoservicelargersectionsofthepopulationandaddressspecificneeds.
11

ThePublicSectoriskeentocontinuetoencourageprivateinvestmentinthehealthcaresector andisnowdeveloping
PublicPrivatePartnershipsi.e.PPPmodelstoimproveavailabilityofhealthcareservices and provide healthcare
financing.
BothsectorshavealsoundertakeninitiativestoimprovefunctionalefficienciesintheformofAccreditations,Clinicalr
esearch,outsourcingofnon-coreareas,increasedpenetrationofhealthcareinsurance and third party payers.
These issues and initiatives have been further discussed in the ensuing sections.

10

KPMG Analysis
National Health Policy, 2002

11

Changing disease patterns:


Implication for healthcare
infrastructure
Changesinthelifestyleofthepeopleareresultinginadualdisease
burden.Thisemanatesfromthecomplexityofcommunicableandnoncommunicablediseasesintheruralandurbanregionsofthecountry.
Theoccurrenceofthesediseasepatternshasimpactedthehealthcare
infrastructurerequirementsandhasresultedininfrastructural challenges
for the government and the private players.
Changing Disease Trends
Indiaratespoorlyoneventhebasichealthcareindicatorswhenbenchmarkedagainstnotonlythedevelopedeconom
ies,butalsotheotherBRICnations.Thisisevidenceofthefactthatasignificantportion of the Indian population is
unable to access healthcare services. This is a consequence of:

Lack of healthcare infrastructure

Lack of trained and qualified manpower

Indicator
Life expectancy at birth (years)
Infant Mortality Rate
(probabilityof dying by age 1
per 1000 livebirths)
Maternal Mortality Rate
(per100000 births)

Year
2008

2008

200009
Source: WHO, World Health Statistics, 2010

India
64

Developed
Economies
US
UK

Emerging Economies
Japan
83

Braz
il73

Russi
a 68

Chin
a74

18

18

77

24

34

78

80

52

254

13

These issues have been examined and discussed in the sections below.

Changing Disease Pattern: The Dual disease burden


Indiasurbanpopulationhaswitnessedanincreaseof4.5timesover195112

2001comparedtoa3timesincreaseinthetotalpopulationoverthesameperiod .Withincreasingurbanizationandth
eproblemsassociatedwithmoderndaylivinginurbansettings,thediseaseprofilesareshiftingfrominfectioustolifestyle13

14

related. Itisestimatedthatby2012,50%ofthespendingoninpatientbedswouldbeforlifestyle-related diseases .

12

IDFC Securities Hospital Sector November 2010


IDFC Securities Hospital Sector November 2010
14
Strategic Healthcare Solutions Private Limited, Article Healthcare: Destination India, 2007
13

Indiafacesthefollowingchallengesindiseasecontrol:

TacklingmaternalandinfantmortalityaswellascommunicablediseasessuchasTuberculosis,vectorbornediseasesofmalaria,kala-azarandfilaria,water-bornediseasessuchascholera,diarrhoeal
diseases,
leptospirosis, and thevaccine-preventablemeaslesandtetanus
Tacklingrisingoccurrenceofnon-communicablediseases(NCDs)includingcancers,diabetes,cardiovascular
diseases, chronic obstructive pulmonary diseases and injuries
Developingsystemstocopewiththecategoryofthenewandre-emerginginfectiousdiseaseslikeHIV,
avian
15
influenza, SARS, and H1N1 influenza

Burden of Non Communicable Diseases


Disease

Number of Cases

Cardiovascula
r

3,80,41,09
0

Diabetes
COPD
Cancer

3,10,39,93
2
1,70,20,00
0
20,16,700

Deaths 2005*
20,89,5
0
8

Projected
Numberof
Cases6,40,71,98
2015**
1

N/A
N/A
5,38,85
8

Projected
Deaths20
15**
34,20,752

4,58,09,14
9
2,22,10,00
0
24,96,133

N/A
N/A
6,66,563

*CVD/diabetes data from 2005; COPD from2006;cancerfrom2004.


** Projected data for CVD/diabetes is for2015;COPDis2016;canceris2014.

Source:WorldHealthOrganisation,WorldHealthStatistics2010
ThefourleadingchronicdiseasesinIndia,asmeasured by their prevalence, are cardiovascular
diseases(CVDs), diabetes mellitus (diabetes), chronic obstructive pulmonary disease (COPD) and cancer.
All fourof these diseases are projected to continue to increase in prevalence in the near future given
16

thedemographic trends and lifestyle changes in India .

Healthcare infrastructure deficiencies


ThepenetrationofhealthcareinfrastructureinIndiaismuchlowerthanthatofdevelopedcountriesandeven lower
than the global average.

Current Infrastructure
The healthcare infrastructure in India is inadequatecomparedwiththeglobalstandards.Itlagsbehindtheglobal
average in terms of healthcare infrastructure and manpower. India has an average 0.6 doctors
17

per1000populationagainsttheglobalaverageof1.23 which suggests an evident manpower gap.


Indicators

HospitalBedDe
nsity(per10000
population)
DoctorDensity
(per10000pop
ulation)

Year

India

USA

UK

Brazil

China

2000-2009

12

31

39

24

30

2000-2009

27

21

17

14

15

AR, Government of India Ministry of Health and Family Welfare, September 2010
WorldHealthOrganisation,WorldHealthStatistics2010
17
CII, Technopak report
16

7
2011KPMG,anIndianPartnershipandamemberfirmoftheKPMGnetworkofindependentmemberfirmsaffiliatedwithKPMGInternationalCooperative(KPMGInternational),aSwissentity.Allrightsreserved.

Indicators

Birthsattende
dbyskilledheal
thpersonnel(p
ercent)
Noofdoctors
No.ofNurses
No.ofDentists
Avg.no.ofdoct
orsperbed

Year

2000-2009
2009

India

USA

47

UK

99

2009

6,43,52
0
13,72,05

2009

55,3

2009

Brazil

NA

7,93,64
8
29,27,00

China

97

1,26,12
6
37,20

98

3,20,01
3
5,49,42

18,62,63
0
1225924

4,63,

25,9

2,17,

1,36,

0.6

0.

0.

0.

0.

2009

1.27

0.

1.

3.

No.ofdoctors
per1000pop
ulation
No.ofnurses

2009

0.6

2.7

1.4

per1000pop

2009

1.3

9.8

Avg.no.ofnur
sesperbed

ulation
Source
:www.oecd.org,www.whoindia.org

In2009,thenumberofbedsavailableper1000peopleinIndiawasonly1.27,whichislessthanhalftheglobalaverageo
18

f2.6.Thereare369,351government beds in urban areas and a mere 143,069 beds inrural areas .
2008
Additional

1.1 million

2018
3.1 million

2028
2 million

BedsRequire
d
Bed/1000po

0.7to1.7

pulation ratio
Source: CII Technopak
Atsixdoctorsper10,000people,thenumberofqualifieddoctorsinthecountryisnotsufficientforthegrowingrequirem
entsofIndianhealthcare.Moreover,ruraldoctorstopopulationratioislowerby6timesas compared to urban
19

areas .

Parameter

Current Annual Production

Tofillthegap

Physicians

30,558

9,93,500

Nurses

1,14,218

2,510,250

Source: CII Technopak

18
19

Source:NationalHealthProfile2009
Source: CII Technopak
8

AsofFY10,Indiahadapproximately300medicalcolleges,290collegesforBachelorofDentalSurgeryand140colleg
esforMasterofDentalSurgeryadmitting34,595,23,520and2,644studentsannuallyrespectively.Indianeedstoope
n600medicalcolleges(100seatspercollege)and1500nursingcolleges(60 seats per college) in order to meet
theglobalaverageofdoctorsandnurses.
Moreover, the medical personnel are concentrated in urban areas. Around 74 percent of the
graduatedoctors in India work in urban settlements which account for only approximately one-fourth of
thepopulation. The countrywide distribution of these institutes is also skewed. 61 percent of the
medicalcolleges are in the 6 states of Maharashtra,Karnataka, Kerala, Tamil Nadu, Andhra Pradesh
andPuducherry, while only 11 percent are in Bihar, Jharkhand,OrissaandWestBengalandthenorth-eastern
20
states .

20

Source:TaskForceonMedicalEducationfortheNationalRuralHealthMissionandTheNationalMedical Journal
of India Vol. 23, No. 3, 2010

9
2011KPMG,anIndianPartnershipandamemberfirmoftheKPMGnetworkofindependentmemberfirmsaffiliatedwithKPMGInternationalCooperative(KPMGInternational),aSwissentity.Allrightsreserved.

E erging Trends i Healthcare


Deliv ry
In the last decade, private participation in thehealthcare sector has
ris n significantlyon the back of i creased interest by investorsand
rising Private Equityand MergersandAcquisitions(M&A)
activity.Futher,thesectorhasalso evolved through increased
investment inR&D and the introduction of specialiseddeliverymodels.
Investment Trends
Driven byincreas d domesticdemand forhigh-

nd investment servicesas well as medical tourism, the

healthcare sector hasattracted huge investmentslately. The healthcare sector islikelyto see anincreasein
investment from USD34.2bn in 2006 to USD 78bn in 2012E (CAGR of 15percent), with ~80percent of
2
investments from private players. The investmentsto thisscale are expected to increase the bed ratio
from 0.9 bedsper 1000peopleto 1.85 bedsper 1000people.
Moreover, large scale investmentsin infrastructure are
requirdevelopedcountries.

22

d to make healthcare facilities on par with

Source: Centrum Healthcare Sector October2010

Foreign DirectInvestment(FDI)
TheFDIinflowsinthehospitalsect

rhavenotbeensignificantlyhighdespitegovern

entincentivesto

attractFDIinvestments(including100percentFDIinmosthealth-relatedservices).Therearec
limitednumberof100percentforeign-ownedh

rrently

althcareplayersintheIndianmarket.However,this

scenarioisexpectedtochangegiventheattractivenessofthesector.Manyforeignplayersaremakingaforayintothe
marketthroughjointventureswithlocalhealthcareunits.Forexample,Singapore'sPacificHealthcaremadeitsfirstfo
rayintotheIndianmarket,openinganinternationalmedicalcentre,whichisa
21

Source: Centrum HealthcareSector October2010

1
0
2011KPMG,anIndianPartnershipandamemberfirmoftheKPMGnetworkofindependentmemberfirmsaffiliatedwithKPMGInternationalCooperative(KPMGInternational),aSwissentity.Allrightsreserved.

22

Source: Centrum HealthcareSector October2010

1
1
2011KPMG,anIndianPartnershipandamemberfirmoftheKPMGnetworkofindependentmemberfirmsaffiliatedwithKPMGInternationalCooperative(KPMGInternational),aSwissentity.Allrightsreserved.

jointventurewithIndia'sVitaeHealthcare,intheIndiancityofHyderabad.SingaporebasedParkwayGroupHealthcarePTELtdhadenteredtheIndianhealthcaremarketin2003throughajointventurewi
ththeApollogrouptobuildtheApolloGleneagleshospital,a325-bedmulti23

specialityhospitalatacostofUSD29million andislookingatajointventureforanothertertiarycarehospitalinMumba
i.Many
internationaldiagnosticcareplayershaveentereare
Indiaandothersincludingmedicaleducationplayers
looking keenlyat sectoral entry points.

Source: Indiastat
*FDIforHospitalsandDiagnostic Centres, Medicaland Surgical Appliances, Drugsand Pharmaceuticals

M&ADeals
Pharma,biotechandhealthcaresectorhasseensignificanttractionoverthelastfouryearswithdealvaluesrangingfr
omUSD1.5billionin2007toUSD6.2billionin2010.Healthcareservicesaccountedfor14percentofthetotalM&Adeal
valuein2009.Pharma,biotechandhealthcaresectorsawinboundM&Adealsto
thetotalM&A deal value in 2010.

thetune

of

52

percent

of

24

2007

Nu m
ber
NA

o
Value (USD billin)
1.5

2008

NA

5.5

2009

23

1.5

2010

57

6.2

Source: Grant hornton DealTracker

PrivateEquityInvestment
TherehasbeenanincreaseinthePEandVCactivity(bothdomesticandglobal)overthepastcoupleof
years. These investments have been made across the healthcare delivery chain. However, these
investments are mostly made intertiary

care hospitals inmetros/tier

IIcities,

chains ofhospitals,

diagnosticlabs, etc.

2011KPMG,anIndianPartnershipandamemberfirmoftheKPMGnetworkofindependentmemberfirmsaffiliatedwithKPMGInternationalCooperative(KPMGInternational),aSwissentity.Allrightsreserved.

23
24

Source: IDFCSecuritiesHospital SectorNovember2010


Source: Grant Thornton DealTracker, 2010
11

2011KPMG,anIndianPartnershipandamemberfirmoftheKPMGnetworkofindependentmemberfirmsaffiliatedwithKPMGInternationalCooperative(KPMGInternational),aSwissentity.Allrightsreserved.

Theprivateequityinvestmentsnearlydoubledinvaluein2010forthepharma,healthcareandbiotechsector. A
number of PE investors invested in hospitals and healthcare services.
Number

Value (USD billion)

2009

15

148.5

2010

23

320.4

Source:GrantThorntonDealTracker,2010

Developments in Research
Healthcareresearchisacorefocuswithinthehealthcaresector.IntheUnionbudget2010/11,theexpenditurebudget
oftheMinistryofHealthandFamilyWelfareforhealthresearchincreasedby25percentY-o25

YcorrespondingtoUSD110millioninabsoluteterms. NotableresearcheffortsinthelastfewyearsincludeWellque
stsresearchcentreinHyderabadandBioconIndiasandBristol-MyersSquibbs joint R&D centre at Biocon's
26

SEZ in Bangalore .
Moreover,risingR&DcostsanddecliningR&Dproductivity,hasledtooutsourcingbeing
a
keystrategyforimprovingprofitabilityforglobalinnovatorcompanies.ThishasbeenakeydriverforthegrowthofContr
actResearchandManufacturing Services (CRAMS) in India.

Contract Research in India


ContractResearchisafastemergingbusinessopportunityforIndiancompanies,particularlyformidsizedcompanie
s.
ThemarketsizeofcontractresearchinIndiain2009wasUSD0.9billioncomparedwithUSD0.6billionin2008,agrowt
hof50%.PlayersintheIndianCROmarketintheyear2005were20andincreasedto100in the year 2008. These are
expected to be in the range of 150-200 in the year 2012.
Hospitalchainsareventuringintocontractresearchtoreducetheiroperationalandclinicalcosts.FortisHealthcareha
sbecomethelatestentrantincontractresearchwithitsFortisClinicalResearchServices.ApolloHospitalssitemana
gementorganizationApolloSpectraResearchFoundation
hasbeenmanagingclinicaltrialsforsomeyearsnowandtheMaxgroup,ownerofMaxchainofhospitals,hasacontrac
t research organization called Neeman Medical International.
About60percentoftheglobalclinicaltrialsmarketisoutsourcedtodevelopingcountrieslikeIndia.Indiangenericphar
macompanieslikeDaiichiSankyo,DrReddysalongwiththeglobalplayerssuchasPfizerand Merck are involved in
27

the outsourcing in the Indian market .

25

Economic Intelligence Unit Healthcare November 2010


Cygnus, Industry Insight - CRAMS 2010
27
Cygnus, Industry Insight - CRAMS 2010
26

12

Emerging Trends in Clinical Research


Clinicalresearchinmanyspecialitieshasledtoimproveddiseasemanagementandpatientcare,reducedALOS,bett
erBTR(BedTurnOverRates)makinghealthcaredeliverymoresustainable.Thisalsosignificantly improves the
DALY (Disease Adjusted Life Years).
ResearchinbetterdiagnosticcarehasbeeninbothlaboratorymedicinemovingtohighergenerationELISAs,NAT(N
ucleicAcidTesting),movingtomoleculardiagnostics,immunologyandantigentesting,evolvingdiseasemarkersan
dsoon.Ontheradiologyfronttootherehavebeensubstantialimprovementsfromtraditionalmethodstocomputerisa
28
tion,PACS(PictureArchivedComputerisedSystem),betterradiation dose control and so on.

Stem Cell Research


Stemcelltherapyinvolvestherebuildingorreplacingofcellsdamagedduetogeneticanddegenerativedisordersincl
udingagerelatedfunctionaldisorders,autoimmunediseases,cardiovasculardisorders,ParkinsonsandAlzheimersdiseas
es,differentcancersetc.Scientistsareworkingtocreatestemcelltherapies that might help tackle a variety of
disorders,andwillhelpintheregenerationof a neworgan.
InIndia,theDepartmentofBiotechnologyhasallocatedmorethanUSD66Millionoverthelastfiveyearstowardsbasic
andappliedresearchinstemcelltechnology.Thefocusistounderstandthefundamentalsofstemcellsfunctionandco
nductclinicaltrialstogaugetheeffectivenessofthetherapy.NationalCentrefor Biological Sciences (NCBS) in
29

Bangalore is involved in this .


AvarietyofinstitutessuchasAIIMS,L.V.PrasadEyeInstitute,CentreforStemCellResearchatCMCVelloreandNati
onalCentreforCellSciences(NCCS)atPuneUniversityarefocusedonapplicationsforspecifically three areas:
Regeneration of damaged muscles due to heart attack, stroke or cornea damage.this confirms to the high
incidence rate of heart attack, blindness and stroke in India.
Thetaskoftheseinstitutesistolocatepromisingsourcesofstemcells,applystemcelltherapytocurepatients
verify if the procedure is stable enough for wider application.

and

Theprivateeffortshavebeen
a
greathelpinthiscontext.DrSatishPatkietalandDrNareshTrehanhavedemonstratedsuccessfulmodelsforstemcellresearchinIndiawithtestsonendometri
umandbonemarrowcellsrespectively.Reliancelifescienceshavebeengiventhenodforventuringintostemcellrese
arch in India
StoringthestemcellscanbeofgreatbenefittothehealthcarefraternityCompanieslikeRelianceLifeSciences,Lifecel
lhaveandStemadehavecreatedfacilitytostorestemcellsfromumbilicalcordandmilkteeth.Stemcellbankingthereforeisemergingasahotdestinationforinvestments.ItsmarketinIndiaistoutedtobeaboutUSD22M
30

illion,andisgrowingatover40percentperyear .

28

Source: Cygnus, Industry Insight - CRAMS 2010


Source:DepartmentofBiotechnology,AnnualReport2010
30
Source: DNA, Stem-cell bankers seek to tap India September 2010
29

13

Drug Eluting Stents


31

Deathsduetocardiacailmentswillincreaseby100percentinIndiaby2015 .Drugelutingstents(DES)are
increasingly being used in the treatment of coronary artery diseases.
OneofthemajorbenefitsofDESisthattheprocedureisminimallyinvasiveandtheperformanceisequalorbetterthanb
aremetalstents(BMS).Eventhoughpolymersareimportantinkeepingthedrugintact,polymerfreeDESarelikelyto
minimizeDES-relatedcomplications.AninterestingfacetofresearchisbeingundertakenatSuratbasedEnvisionScientific.Thejudiciousapplicationofnanoparticleswillincreasethecellabsorptionandthusreducet
hecomplicationsofthedrugandpolymersNanocarrierdeliverycanbeusedfordifferentmedicalapplications.Comp
anieslikeEnvisionscientific,BBraun,areaddressingthesekeyissueswithlandmarkresearches.Thelatestresearchinthisfieldisdrugelutingballo
32
on (balloons without stents) which will travel the artery and act at the wound site.

Hospitals and Research


InIndia,manycorporatehospitalsandmajorpublichospitalsareactivelyinvolvedinconductingclinicaltrials
various drugs.

of

PrivatecorporatehospitalssuchasApolloCare,NarayanaHrudayalaya,UshaCardiacInstitute,ShankarNetralaya
,Indraprastha,BreachCandy,andBayerdiagnostics as well as public hospitals such as All
IndiaInstituteofMedicalSciences,NizamInstituteofMedicalSciencesandmanyoftheMedicalcollegesandteachin
33

g hospitals are actively involvedinvariousstagesofclinicaltrials .


Manyofthemhavestate-of-theartinfrastructurefacilitiesforconductingclinicaltrialsandtreatingpatients.Thesehavenotonlyhelpedinimprovingp
atientoutcomesbutalsohelpedintacklingincreasedvolume of patients suffering from debilitating diseases.

Developments in Private Healthcare


Evolving Delivery Models
Day care Centres
Need:Theconceptofout-patientsurgeriesisgrowingworldwideasinpatientfacilitiescanbeexpensiveandinconvenientinsomecases.Alargenumberofsurgeriescannowbeperformed
withoutthepatienthavingtobeadmittedatallwiththehelpofDaycareSurgeryCentres.Thisdeliverymodelisadvanta
geousforbothhealthcareprovidersandconsumers.Itisestimatedthatby2020,75percentofallsurgicaloperationswi
34
llbecarriedoutinambulatorysurgerycentres/units .Todayoveraquarterofthesurgeriesarecontributedbyophthal
micprocedures.Thecostadvantageofdaysurgeryisbestachievedin
free-standing
centres
or
freefunctioningunitswithinhospitals.

31

Source: Express Pharma Online, Lupin launches Ivabrad, 2008


Source: KPMG Analysis
33
Source: Cygnus, Industry Insight - CRAMS 2010
34
Source: indianhealthcare.in
32

14
2011KPMG,anIndianPartnershipandamemberfirmoftheKPMGnetworkofindependentmemberfirmsaffiliatedwithKPMGInternationalCooperative(KPMGInternational),aSwissentity.Allrightsreserved.

InIndia,theconceptofstandalonedaycaresurgerycentresiscurrentlyinitsinfancy.Manyofthemajorhospitalshaveaseparatedaycaresurgeryc
entrewhichcaterstothemanagementofambulatory(alsocommonlyreferredtoassamedaysurgery)procedures.I
35

nIndia,about20percentofallsurgicalprocedures are performed on outpatients .


36
Studiesrevealthattreatmentinthesecentreswouldcostabout47percentlessthaninhospitals ..This
37

model can be economically efficient for the Indian healthcare which is scarce in resources .
Potential Benefits:
The range of services provided and the cost arethe prime benefits of the day care services.
Inahospitalwiththedaycareservicesthesurgerydepartmentprovidesservicesforeyesurgery,includingremovalof
cataracts,eyemusclesurgery,Arthroscopicsurgeries,Generalsurgery,Cosmeticsurgeryandremovalofforeignbo
dies,providingthepatientwithplethoraofservicesinasmalltimeframe.
Anaveragecorporatehospitalontheotherhandtakesaminimumof18monthsinthemakingandaminimumofthreeto
fiveyearstobreakeven.Companyexecutivespointoutthateveninahospitalsetuparound75percentofrevenueisfin
allymadefromthesurgeries.Thisfactfurthersupportsthegrowthofday care centres.
CapexandEBIDTA:DuetothedependencyonthespecialityandlevelofcarethataDayCareCentrewouldcatertoitis
difficulttopendownanindustryaverageontheCapexbutafairindicatorwouldbeINR
3.5 4.5Million/bedforaninternationalstandarddaycarecentre.EBIDTAmarginsforDayCarecentresrange between
38

25 percent and 30 percentwith a pay back of ~34 years .


Case
39
Studies :
NOVA DAY CARE CENTRE
ThepromotersandtheUS-basedprivateinvestmentfirm,plantosetuparound100daycaresurgerycentresinthenextthreetofouryearswithaninvestmentofoverINR800crore.Thecompanyexecutive
s'claimthatthepatientscouldsaveabout1520percentinsurgerycostsatNova'sdaycarecentrescomparedtothecorporatehospitalsrates.
"Thelowcostmodelandthehighefficiencyratesof450surgeriespermonthpercentrewouldmakeitabefittingmodelforIndi
a,whichhasabedtopopulationratioof0.7perthousandpersonscomparedtotheworldaverageof3.3.Overnightro
omcostsandrelatedoverheadcostsareeliminatedandthemodelenables surgeons to attend to more patients
in less time.
Itessentiallyaspirestofocusonminimallyinvasivesurgeries,whichusethetechnologicaladvancesinmostoptimu
mmanner.ThedaycaresurgerymodelhasamarketpotentialofINR42,000croreinthecountry.
(SureshSoni,chairmanandcofounder,NovatoldFE.)Inthefirstphase,thegroupplanstobuild25centresin10majorcitiesinthenexttwoyears.Th
35

Source:indianhealthcare.in
Source:indianhealthcare.in Daycare Surgery 4 Centres, 2010
37
Source: Article by Express Healthcare
38
Source: KPMG Analysis
39
Source: Company Websites
36

15

MedicalCentres,aspecialiseddaycaresurgerycentre chain,andMaxHealthcareInstituteLimited(MHC)recentlyan

End of life care centres


Need:Inmedicine,end-oflifecarereferstomedicalcarenotonlyofpatientsinthefinalhoursordaysoftheirlives,butmorebroadly,medicalcareof
allthosewithaterminalillnessorterminalconditionthathasbecome advanced, progressive and incurable.
Therefore end of life care centres have three objectives

To reduce the agony and burdenofprolongeddyingprocess

To develop mental peace at the time of death

ToestablishethicalprinciplessupportingdeathintheIndianhospitals
PotentialBenefits:Byincreasingtheproportionofcommunityandhomecare,palliativecarecanreducecostsassoci
atedwithhospitalstaysandemergencyadmissionsmuchpalliativecarecanbeandisgivenat home.
InIndia,over138organisationsprovidehospiceandpalliativecareservicesin16statesorunionterritories.Theseser
vicesareusuallyconcentratedinlargecitiesandregionalcancercentres,withtheexception of Kerala, where
41

services are more widespread .


Palliativecare structure inIndia

PallativeCareSetting

Regionalcarec
entres&freestandinghospi
ces

DayandHome
CareServices

Single Speciality Hospitals

OutreachClinics

Government&P
rivate Hospitals

Need:SinglespecialityhospitalsareasmallbutrapidlygrowinggenreamongtodayshospitalsinIndia.Thegrowingn
umberofspecialitycentresandhospitalssignalsamovetowardsmaturityofthehealthcareindustry
with
an
increasing complexityof business and consumer affordability.

40
41

Source: Financial Express February 5, 2010


Source:DepartmentofSocialPolicy&SocialWork, University of York, York, United Kingdom
16

Specialityhospitalformatsrangefromlow-riskspecialityincludingeyecare,dermatology,motherandchildtohighendspecialityincludingcardiology, cancer and transplant medicine.


Themid-levelspecialitiesareofferedinamultispecialityhospitalformat.Thelowriskspecialitymodelsrequirelowcapitalexpenditureandhavecomparativelylowoperatingcostsasinpatientstayisrarelyrequiredfordayprocedures.Thisreducestheneedforsupportinfrastructureandofferseasyrepli
cation.Consumers expect convenience and are not willing totravel too far for such speciality services.
Potential Benefits:
There are several advantages to Single Speciality Hospitals

Cost efficiency due to higher volumes

Providehigherqualitycareduetogreaterspecialization

Easily attract human resource

Economiesofscaleandscope

Ease of operation

Increase consumer satisfaction

Competitivepricingandincreasedchoiceforconsumer
CapexandEBIDTA:CapitalExpenditureisestimatedatINR4toMillion/beddependingonthespecialty.TypicalEBID
TAmarginsrangefrom30percentto34percentalthoughsomespecialitieshavehighermargins. Pay Back period is
42

estimated at 23 years which may vary with the speciality .


Case Studies:

43

Arvind eye care


3,950bedsatfivehospitals.
Examines more than two million patients annually.

Arvindsurgeonperformsanaverageof2,000ormoresurgeriesperyear,measuredagainsttheIndiannational
average of 250.
Bydevelopingacorecompetencyexpandingaccessinafocusedareaofcareorganizationsindevelopingcountri
escanmarshalneededresources.
BeingaspecialtycaresystemhasmadeiteasierfororganizationssuchasArvindtostandardizemanagementan
dclinicalprocesses,trainaspecializedparaprofessionalworkforce,pursuelower-costtechnology, and build
volume with focused community outreach and education

Mohans diabetic care

61beddedin-patientdiabetescareunitSpecialistconsultationsinthefieldsofcardiology,neurology,nephrology,
urology, dermatology, ophthalmology, psychology, orthopaedics and paediatrics
Staff have been trained and prepared for emergency care
Wide range of surgical services for the diabetes patients with three well equipped operation theatres.

42
43

Surgeries related to diabetic foot complications, general and eye surgeries (cataract and
glaucoma)are routinelydone.

Source: KPMG Analysis


Source: Company Websites

2011KPMG,anIndianPartnershipandamemberfirmoftheKPMGnetworkofindependentmemberfirmsaffiliatedwithKPMGInternationalCooperative(KPMGInternational),aSwissentity.Allrightsreserved.

17

2011KPMG,anIndianPartnershipandamemberfirmoftheKPMGnetworkofindependentmemberfirmsaffiliatedwithKPMGInternationalCooperative(KPMGInternational),aSwissentity.Allrightsreserved.

Ayurvedic and Wellness Care


Ayurvedictreatmentsare5,000yearsoldinIndiawiththebulkoftheayurvedictreatmentmarketconcentratedinSout
44

hIndia,mostlyinKerala .PEfirmsarealsoinvestinginthisspacewhilemergerswith ayurveda pharmacies are


also taking place.
45

Ayurvedicmarket(whichisapartoftheBeautyandRejuvenationmarket)isestimatedatINR40Billionin2009 .Indiai
sapopulardestinationforayurvedictherapiesleadingtoalargenumberofforeigntouristsvisitinglocalspasandayurv
edictreatmentcentres.InboundmedicaltourisminIndiaisthereforegrowingat a 12 percent CAGR.
TheStategovernmentofKeralaalsohastakencertaininitiativestoencourageAyurvedicspasandresortsas
touristdestination.Spa'sinKeralareceive government approval when they are set up.

Ayurvedacentreswhichareapproved/certifiedbytheStateDepartmentofTourismareeligibleforclaiming10percent
stateinvestmentsubsidyorelectrictariffconcessionandconsideredduringpublicityand promotional activities
through print and electronic media by the Department
Keralagovernmenthasevencollaboratedwithlargeprivateplayersinordertodevelopresortspas.Inordertoattractto
uristsintoIndia,theGovernmenthasintroducedvariousschemesandtoimplementthemithasalsotiedupwithleadin
gwellnesscentres.TourismministrylaunchedapromotionalschemeofferingonenightfreestayataspacentreinIndi
46
aifatouristbooksthreenightsatacertainwellnesscentres
Hospitals are also setting up wellness centres to cater to the requirements of the medical tourists

ApolloHospitalshasanentitycalledApolloWellnessPluswhichhasfitnessandayurvedictreatmentcentres

ManipalHospitalsprovidesayurvedictreatment,fitnesssolutionsthroughManipalCureandCare

47

48

Case Studies :
Kerala Ayurveda Ltd.
Ramesh Vangal owned KAL was founded in 1945
It is listed on Bombay Stock Exchange

Ithas30wellnesscentreswhicharemostlyconcentratedinthesouthbutitalsohasitspresenceinthe north

It owns Kerala Ayurvedegram that is present in Bangalore

IthasenteredintoanExpressionofInterestwithCoimbatorebasedAryaVaidyaPharmacytobecomethe largest
Ayurveda Utility

Ananda Spa

IthasdestinationspasinTehri-Garhwal,UttaranchalwhichprovidesTreatmentbasedonayurvedicscience via
herbal scrubs, wraps and packs

44

Source: Research on India, Wellness Services Market Report, 2010


Source: Research on India, Wellness Services Market Report, 2010
46
Source: Kerala Tourism; India PR Wire Bharat Hotels; Kerala government to develop resort;
May2009;AlishaTravels
47
Source: Research on India, Wellness Services Market Report, 2010
48
Source: Company Websites
45

18

VCC Ayurveda and Panchakarma Clinic


It is located in central Kerala

ItprovidesKeralaMassagetherapy,relax-detoxtherapy,rejuvenationtherapy,anti-ageingtherapyand also
has weight loss programs

Kare
Kerala Ayurvedic Research and Rejuvenation is located on the outskirts of Pune
Its services include ayurvedic massage therapy,anti-ageingayurvedictherapy

Developments in Public Healthcare


Initiatives by the Government
Totacklethechallengesmentioned,theGovernmenthastakenvariousinitiativestoimprovethePublicHealthcaresy
steminIndia.TheGovernmentlaunchedtheNationalRuralHealthMission(NRHM)in2005whichaimstoprovidequa
lityhealthcareforallandincreasetheexpenditureonhealthcarefrom0.9percent of GDP to 2-3 per cent of GDP
by 2012.
AccordingtoUnionBudget2010-11,theplanallocationforMinistryofHealthandFamilyWelfarehasincreased from
USD 4.2 billion in 2009-10 to USD 4.8 billion in 2010-11.
Moreover,inordertomeetrevisedcostofconstruction,inMarch2010thegovernmentallocatedanadditionalUSD1.2
49

3billionforsixupcomingAIIMS-likeinstitutesandup-gradationof13existingGovernment Medical Colleges .


TheUnionCabinetonOctober20,2010approvedtheproposaloftheMinistryofHealthandFamilyWelfaretodeclare
NationalInstituteofMentalHealthandNeuroSciences(NIMHANS),BangaloreasanInstituteofNationalImportanc
eonthelinesofAllIndiaInstituteofMedicalSciences,NewDelhi,PostGraduateInstituteofMedicalEducationandRe
search,ChandigarhandJawaharlalInstituteofPostgraduate Medical Educationand Research, Puducherry.

Private-Public Partnerships
TheIndianGovernmentisfocusedondevelopingthePPPmodeltocoverthedemandsupplygapprevalentinthehealthcaresector.Privatesectorexpertisecoupledwithefficienciesinoperationandmaint
enancewouldleadtoimprovedhealthcareservicesdeliverytothemasses.Thismodelcanactasacatalystinthecreat
ionofnewcapacityandimprovementofefficiencyintheexistinginfrastructureestablished.TheGovernmentalsoem
bracedPPPmodeltocounterepidemicslikeH1N1swineflu,HIV,etc. However, it is evident that this model be far
more beneficial.

ThecriticalsuccessfactorsforPPPare:

Political Commitment and introduction of requisite regulations

49

Source: Firstcall Research, Apollo Hospitals Enterprise Limited Company Research Report, Q2, 2011
19

Policy and legal framework for operating PPP models

Strong control mechanisms for efficient oversight including dispute resolution procedures

Risk apportionment through careful design of the contract

Incentivize the private sector with an acceptable rate of return


50

Few successful PPP projects are mentioned below :

Karnataka Karuna Trust; Yashaswini Scheme

Tamil Nadu Mobile health services

Andhra Pradesh Aarogyasri

Andhra Pradesh Diagnostic Services for 4 Medical Colleges

West Bengal Mobile health services

Madhya Pradesh Community outreach program

Rajasthan Contracting in publichospitals

Gujarat Chiranjeevi Project

2011KPMG,anIndianPartnershipandamemberfirmoftheKPMGnetworkofindependentmemberfirmsaffiliatedwithKPMGInternationalCooperative(KPMGInternational),aSwissentity.Allrightsreserved.

50

Source: Technopak Report A Peek into the Future of Healthcare: Trends for 2010
20

2011KPMG,anIndianPartnershipandamemberfirmoftheKPMGnetworkofindependentmemberfirmsaffiliatedwithKPMGInternationalCooperative(KPMGInternational),aSwissentity.Allrightsreserved.

Building Functional Efficiencies


Whileinfrastructureimprovement,capacityadditionanddevelopment
ofmanpowerarecriticalfortheIndianhealthcaresector,itisalso
necessarythattheexistingfacilitiesareoperatedinanefficient
manner.Thiscanbeensuredthroughvariousmeanssuchas
Accreditation,adoptionofCostAccountingProceduresandfinally
increased penetration of Healthcare Insurance.
Accreditation
Accreditationisoneofseveralmodelsofexternalevaluationusedbyhealthcareentitiesthroughouttheworldtoregula
te,improveandpromotehealthcareservices.Domestically,accreditationissoughtfromtheNationalAccreditationB
oardforHospitalsandHealthcareProviders(NABH),anentityunderthecontrol of the Quality Council of India.
JCIaninternationalaccreditationarmoftheUSjointcommissionalsoprovidesaccreditation.FewhospitalsinIndialik
51

eMoolchandHospital;Fortishospitalsetc.havealreadybeenaccreditedbythisbody .

Trends of Accreditation
Todate,only17IndianhospitalsareJCIaccreditedandallarelargecorporateentities,includinghospitalsintheApollo,Fortis,andWockhardtHospitalsyste
52

ms .

AsofMarch2007,over700IndianhospitalshadappliedforNABHaccreditation.TheNABHisinvolvedintheaccredita
tionofbloodbanks,diagnosticcentres,nursinghomes,dentalclinics,andAyurvediccentresinadditiontoprivatehos
53

pitals,nursinghomes.AsofJanuary1,2008,only12medicalfacilitieshavebeenaccreditedbyNABH .

Advantages of Accreditation

Patientsbenefitintermsofhighqualityofcareandpatientsafety.Theyareservicedbycredentialmedicalstaffand
theirrightsarerespectedandprotected.
Accreditationresultsinhelpingcontinuouslyimprovetheoverallservicesofthehospitalinordertoprovidehighqu
alitycarewithleastpossiblerisks.Accreditationprovidesanobjectivesystemofempanelmentbyinsuranceand
otherthirdparties.Itprovidesaccesstoreliableandcertifiedinformationonfacilities,infrastructureandlevelofcar
ewitheducationongoodpracticestoimprovebusiness operations.

51

Source: http://www.jointcommissioninternational.org
Source: http://www.jointcommissioninternational.org
53
Source: Gluck: An article from the Saint Louis University Journal Of Health Law & Policy
52

2
1
2011KPMG,anIndianPartnershipandamemberfirmoftheKPMGnetworkofindependentmemberfirmsaffiliatedwithKPMGInternationalCooperative(KPMGInternational),aSwissentity.Allrightsreserved.

Healthcare Insurance
Indian health financing faces a number of challenges including:

Increase in health care costs

High financial burden on poor effecting their incomes

Need for long term and nursing care for senior citizens because of increasing nuclear family system

Increasing burden of new diseases and health risks

Limitedgovernmentfundingleadingtonegligenceofpreventiveaswellasprimarycareandpublichealth
functions

Healthinsuranceisestablishedinmanycountries,however,stillremainslargelyuntappedinIndia.Lessthan15perce
54

ntofIndias1.1billionpeoplearecoveredthroughhealthinsurance .Itmostlycoversgovernmentemployees,share
ofpublicfinancingintotalhealthcareisjustabout1percentofGDP.Over80percentofhealthfinancingisprivatefinanci
ng,muchofwhichisout-of-pocketpaymentsandnotbyany pre-payment schemes.

55

HealthcareFinancing

Social
1%

OutofPocket8
0%

Other
17%

State
12%

Local
2%
Centre
2%

Insurance
3%

Source: Centrum Healthcare Sector October 2010, KPMG analysis


However,healthcareinsuranceisslowlypickinguppaceinIndia.Accordingtothe2010statisticsreleasedbytheIRDA
(InsuranceRegulatoryDevelopmentAuthority),thetotalhealthinsurancepremiumswrittenbynonlifecompaniesandstandalonehealthinsurancecompaniesgrewby25.2percentinFY2010overFY 2009.

54

Source: www.indianhealthcare.in
Source: Emerging Health Insurance in India Anoverview,ByJ.Anita,ActuariesofIndia,GlobalConference
of Actuaries

55

22

2011KPMG,anIndianPartnershipandamemberfirmoftheKPMGnetworkofindependentmemberfirmsaffiliatedwithKPMGInternationalCooperative(KPMGInternational),aSwissentity.Allrightsreserved.

HealthcareInsurancePenetration
9.00%
8.00%
7.00%
6.00%

CA G R 19%

5.00%

4.00%
3.00%
2.00%
1.00%
0.00%
2008

2013

Source: Centrum Healthcare Sector October 2010

Government insurance Schemes


GovernmentinitiativesliketheRashtriyaSwasthyaBimaYojna(RSBY),ComprehensiveHealthInsuranceScheme
(RSBY-CHIS),Kerala;ApkaSwasthyaBimaTrust(ASBT),Delhi;NiramyaHealthInsuranceScheme, Ludhiyana
56

are now actively drivingthe health insurance market in India .


RSBYmayalsobeextendedtoNationalRuralEmploymentGuaranteeAct(NREGA)workerswhoworkedunder the
scheme for 15 days in a year.
Theinitiativescanhelpaddresstheneedsofthepeoplebelowpovertylineaswellastheothervulnerablesections
the society.

of

Emerging role of TPAs:


TheTPAs(ThirdPartyAdministrators)haveaddedtothechangingscenarioofhealthinsuranceinIndia.Theirroleisgr
aduallychangingfromgreenfieldventurestoanestablishedsystem.Theirwidespreadnetworkwithhospitalsandoth
erhealthcareprovidershavecertainlystrengthenedthehealthinsurancestructure in India.
Major TPAs

No of hospitals added to the network

I Care Health Management and Services

2040

E Meditek Services

867

HealthIndiaServices

786

Total coverage by all the TPAs in India

10974

Source: IRDA Annual Report 2010

56

Source: Towers Watson New Planned Launches Article 2010


23

Tobringinuniformityandsmoothfunctioningoftheprocess,theIRDA(Insuranceregulatoryanddevelopmentauthori
ty)hasdirectedtheTPAstoformulatestandardguidelinesandformatsforbettercommunication and transparency
in the system.

Potential benefits:

Visibility of health insurance in the hospitals and amongst the patients could improve

Credibilityofthehealthinsurancepracticeswillhelpimprovedrivingmorenoofpeopleintothesystem.

A formal structure will be created reducing theambiguityinthehealthinsurancedelivery

24

Conclusion
Healthcareisataninfluxofparadigmshiftsintermsofchanging
diseasepatterns,increasingdualdiseaseburdenforbothruraland
urbanIndia.Onthesupplysidetherehasbeenunevendistributionof
healthcareinfrastructureandresourcesposingvariouschallengesto
thesector.Amulti-prongedapproachfromkeystakeholdersis
necessarytoaddresstheissue.Boththepublicandprivatesector
needtoworkintandemtomakehealthcareavailable,accessibleand
affordable. India would need various solutions towards this end.
Way Forward
Public Sector and Government Interventions Now and Ahead:
Improving the Reach and better Quality:

Thegovernmentplanstoundertakebuilding6superspecialitytertiarycarehospitalswithresearchandeducation
centresacrossthecountry.Thesewouldcatertotheweakersectionsmakinghighendclinicalcareavailabletothe
masses.

Encouragingcurrentinitiativesonpubicprivatepartnerships,forboththecareproviderandeducationsectors,
should continue.

ThegovernmentshouldcontinueflagshipprogrammessuchassuchasRashtriyaSwasthaBimaYojana
(RSBY) and State level Insurance schemeslike the Arogyashri, Chiranjeevi etc.

Atthebaseofthepyramid

Toimproveavailabilityofmedicalstaffinruralandfar-

flungandinaccessibleareas,doctors,specialistsandparamedicalsaregivenmonetarybenefitssuchas25percenthiketothosepostedindifficultareasand50percenthikef
orthoseinareasthatarealmostunreachable by road.

AtruncatedmedicalcoursedesignedbytheCentralGovernmentfromtheChinesebarefootdoctorsmodelthati
57

sassumedtoproduce145,000ruraldoctorseveryyearwhichwouldcovermostprimarylevelneeds .Theexistin
ghealthsub-centres,thefirstpointofcareforvillagers,arenowbeingmanned by Auxiliary Nurse Midwives
(ANM).

ThroughNHSRC,theNRHM(NationalRuralHealthMission)isencouragingalmost200hospitalstogofor
sustainedQualityAccreditationprogram andthisissoughttoextendto400hospitals.

TheCGHS(CentralGovernmentHealthServices)hasmadeitmandatoryforallhealthcareinstitutionsanddiagn
osticcentresprovidingcaretohaveeitherNABH / NABLcertification.

58

Healthcare Education :

Tomeetthedemandformorehumanresources,especiallythedoctorsandnursesthegovernmenthasreducedt
helandrequirementsfrom25acresformedicalcollegesto10acresinurbanareas.TheINC norm of 4 acres for
nursing colleges has also been relaxed.

57
58

Source: FICCI Report, 2010


Source: Government Regulation issued by MedicalCouncilofIndia&IndianNursingCouncil
25

PrivatemedicalcollegesareallowedtoconducttheirownCETandthereservationcriteriaforgovernmentseatsa
ndmanagementquotahavebeenrelaxedwithauniformpredecidedfee.OnlytheNRIreservationismaintainedat15percent.

PrivatemedicalcollegesarenowallowedtoregisterunderSection25Act,unlikeearlierwheretheyhad
under the Charitable Trust banner.

to

be

59

Tax Benefit Interventions :

AllnewhospitalsbeingsetupinTierIIandTierIIItownsofIndiaaregivenafiveyeartaxholidaybythegovernment.T
heUnionBudget2009
2010hasstayedtheorderandthiswindowisopenfromApril1,2008toMarch31,2013,duringwhichthehospitalm
ustcommenceoperations.Hundredpercenttaxdeductiontoprivateinvestorsonthecostofbuildinginfrastructur
eforminimum100bedhospitals anywhere in India.

Forthediagnosticandmedicalequipmentandconsumablesegment.Uniformconcessionaldutyof5percent.
CVD
of
4
percent
with
exemption
from
specialadditionaldutyonmedicalequipment;retainingfullexemptiononassistivedevicesandmedicalrehabilit
ationaids.Weighteddeductionsonpaymentsmade to national labs have been increasedfrom 125 percent
to 175 percent.
60

Import Duty Concessions :

Reduction in Import duty on equipment from 25 percent to 5 percent

Customs Duty reduced from 16 percent to 8 percent for medical and veterinary furniture

Customsdutyon24medicalequipmentlikeX-ray,tele-therapystimulatorequipment,goniometeretc.have
been reduced to 5 percent

Depreciationonmedicalequipmentraisedfrom25percentto40percent
Medical Device Interventions:

ThegovernmentannouncedaUSD69millioninOctober2009topromotedomesticdevicemanufacture
to
enable price control of critical equipment including stents, catheters, heart valves etc,
CentralgovernmenttosetupthefirstspecialiseddevicecentreNationalCentreforMedicalDevicesin Gujarat
61
to promote indigenous R&D efforts

Medical Devices Regulation Bill has been tabled and is under consideration

62

EnablingITdrivenhealthcaretoimprovethereachandcosts.Telemedicine,asabranchofdiagnosisandtreatment,shouldbeencouragedandwidelyimplementedtohelpensure
availabilityandaccessibility of care to all areas in spite of infrastructural inefficiencies

Public Sector Action Items:

Specialbenefits,ViabilityGapFunding,andsubsidiesoncostofcareforPPPinitiativeswouldmakeitmore
attractive for the private sector to participate

Awarenessdrives,IECforHealthInsuranceschemescoveringboththeruralandurbanpoortobeinitiated
through collaborative approach like NGO participation etc.

Incentivize corporate sector to take up healthcare initiatives for CSR activities

59

Thecurrentcompulsoryruralstintformedicalprofessionalstobecontinued.Butneedstobeaugmentedwithbett
erfacilitiesandsupportsystems

Source: Income Tax Act, 1961 read with Income Tax Rules, 1962 & Customs Act, 1962 read
withCustoms Tariff Act, 1975
60
Source: The Customs Act, 1962 read with The Customs Tariff Act, 1975
61
Source: FICCI Report, 2010
62
Source: FICCI Report, 2010

26

Givinganinfrastructurestatustotheindustryandalsoencouragesubsidiesonpower,waterandotherutilities to
reduce overall cost of care

Providingincentivestotheindustrytosetupinfrastructuresinruralareas.Thiswouldleadtoamultipleeffectofimp
rovingtheoveralleconomicandsocialstatusalsomakingitattractiveandsustainableformedicalprofessionalst
owork

Makingitmandatoryforalldiagnosticservicestohavearegistrationprocesswhichlaysdownsomeminimumsta
ndardscriteria.Thiswillhelpintheprovision of better qualitydiagnostic services.

Providingacommondiscussionplatformforallqualitycouncilswhichenforce,assessandmaintainqualitystand
ardsinHospitalsandHealthcareInstitutions(includingeducation).

Private Sector Interventions Action Items:

PrivatesectorshouldworkintandemwiththegovernmentonPPPinitiativestoeducatethelaterfordevelopingmo
resustainabledeliverymodels

Provide Hub and Spoke models for both treatmentanddiagnosticcaredelivery

TakeontheresponsibilityofMedicalEducationwhichincludesmedicalprofessionals,nursing,andparamedical
staff

Toformacommonhealthcareforum/platformtocorroboratealleffortswhichrequirepolicydecisionchanges
which would giving more lobbying power

EncourageandextendCSRinterventionsincrossfunctionalformatsforcapacitybuildingofthepublicsectorpers
onnel.Thiscanbedonethroughexchangeprograms,CMEs,shortstaycertificationsinareaslikehospitaladmini
stration,qualitycontrols,specialisednursingcarelikeintensivecare,operationtheatre,highenddiagnosticstec
hniquesandreportingforlaboratorymedicineandradiologyCT / MRI scans, interventional radiology etc.

Encourage provision locum medical staff forshort durations or on specific programs

Work with the government to encourage better penetration and utilisation of health insurance schemes

Withintheirownsetupsencourageaccreditation,makeitmandatoryforcredentialingofMedicalProfessionals
while recruiting/ appointing to help ensure quality standards.

27

CAS EST UDIES

28

AcuityInformationSystemsPvt.Ltd.
AIIMS, New Delhi deploys acuVena - Blood Bank Software

AllIndiaInstituteofMedicalSciences,AIIMS,isconsideredasoneofthemostprestigiousmedicalcollegesinIndiaan
disgloballyrecognizedforprovidingbestinclassmedicalcaretoalargenumberofpatients.Itwasestablishedasanin
stituteofnationalimportancebyanactoftheIndianparliamentwiththeobjectiveofdevelopingastrongcurriculumand
teachingguidelinesforundergraduateandpostgraduateeducationinallbranchesofmedicineinIndia.TheDepartmentofTransfusionMedicineatAIIMSis
runninga full
timeBlood
BankintheInstituteandalsoorganizingteaching,researchactivities.TheBloodBankfunctionsroundthe
clockandisaRegional BloodTransfusionCentreforsouthDelhi.
AIIMSdecidedtogoinforanend-toendcomputerizationofthebloodbankservicesfrommanagementofdonorstomanufacturingofcomponentsaswell
asadetailedtraceabilitytoensuretheconceptofhaemovigilancefromthestandpointofadonorandtherecipient.AIIMSbegantoreviewsomeofthebest-ofbreedbloodbanksoftwareproductsavailableandarrivedatasolutionfromanIndiancompanybythename
acuis.ThenameoftheirbloodbanksoftwareproductwasacuVena.TheteambehindacuVenahadconcentrat
edonthecomplexitiesoftheworkflowsofindependentandhospitalbasedbloodbanks.Theirsolutionhadbeensucce
ssfullyrunningatmanyofIndiasleadingbloodbanksforthepastfiveyears.acuVenahadbeenshowcasedatindust
ryconferencesinIndiaandtheUSAandhadevolvedbestpracticesfromtheindustryovertheyears.Beinganenterpris
eclass,web-basedsoftware;itseemed to fit in line with the vision of the blood bank at AIIMS.
acuVenapresentsitselfasaprocess-driven,featurerichbloodbanksoftwarethathasbeenbuiltonaServiceOrientedArchitecture.Thekeytoitssuccesshasbeentheinp
utsgivenbythecoreR&DteamconsistingofdomainexpertswhoarestalwartsoftheIndianbloodbankindustry.acuVe
nahasmappedkeystakeholderslikedonors,blooddriveorganizersandcareprovidersinitsdesignfromthegroundup.Thisinsuresthatthesestakeholderscanactivelyinteractwiththesystemratherthanthesystembeingrunessenti
allybytechniciansanddataentryoperators.Thesoftwarecanbebroadlyclassifiedintothefollowing subsystems:
Donor Centricity
Oneofthekeystakeholdersinthesystemisthedonor.Thesystemhelpsmarkdonorsaseligibleanddefersthosewho
arenoteligible.TheentiredonorworkflowhasbeentracedontoacuVenaprocess

29

map.Donorquestionnairesarecompletelycustomizable.Donorscanhavetheoptionofselfregistrationeitherviatheweboraninteractivetouchscreenmodule.Itrecordshistoryofpreviousdonationsandrestri
ctsdonorsfromdonatingbeforetheireligibleperiod.acuVenahastheaddedadvantageofnotlosingtrackofdono
rswhoaretemporarilyunfitfordonationbyremindingthemtocomebackwheneligible.
Bag Lifecycle

acuVenamaintainsthedetailedhistoryofabagrightfromthetimethestoresofficerreceivesit,tillit
isfinallyissuedtotheintendedrecipient.Thesystemacceptsdonorsofwholebloodaswellasaphaeresis.Itallowsco
mponentpreparationdependingonthetypeofbagchosen.acuVenaenablestypingofbloodforRedCell,Leuco
cyteandPlateletAntigen.Onecanviewthetransfusioncentre'sstockaccordingtostocklocation,bloodgrouporcom
ponent.Everystageofthebloodbagfromcollection,componentpreparation,storage,stockmovement,crossmatch,issue,returnanddiscardaretraceablewithinthesystem.Thesystemhasanoptionofautomatic as well as
manual discard of blood components.
Transfusion Care
Thesystemallowsbothinternalandexternalbloodrequests.Incaseoftertiarycarecenters,thebloodbanksalsoserv
eexternalrequestsfromneighboringhospitalsandnursinghomes.Thesystemsupportsbulkissuestostoragecente
rs,emergencyissues,cross-match,issue,returnandbillingofbloodcomponents
in
stock.acuVenaenablesadversetransfusionreactionreporting from the point of care.
Blood Drive (Camp) Management
acuVenahasacomprehensiveblooddrive(bloodcamp)organizationmodulethathelpsbloodbanksorganize
resources (personnel, vehicles, consumables and assets) for blood drives (camps).

DonorLoyalty:acuVenastoresinformationaboutdonorswhoareeligibl
easwellasthosewhomaynotbeeligibletodonatetoday.Thiseligibilityisauto
maticallycalculatedbyanintelligentquestionnairesystemthatcalculatesth
enumberofdaysadonormaybedeferredduetoapreexistingcondition.Sincesuchasystemisrulebased,itallowsthebloodcente
rtochangetheeligibilitydaysdependingontherulessetforthbythegovernin
gregulatory
authority.Storingdataofineligibledonorsnotonlyhelpsthebloodcentercallthembackwhentheyarenext eligible, it
also
enables
the
blood
center
from
pro-activelyknowingthestatusofthedonorifhe/sherevisitsbeforetheyarenexteligibletodonate.Inaddition,thishelpsthebloodcenterconvert(motivate)replacementblo
oddonorsintovoluntaryblooddonorsbycallingthemwhentheyarenexteligibletodonate blood.
FasterTATs(Turn-AroundTimes):Sincethestocklevelsareinstantlyaccessiblewithinandoutsidethe
system,thebloodbankstaffareabletoattendtobloodrequestsinanefficient
manner.Thesystemallowsbloodreservationinadvance.Thesystemhasin
-builtemailandsmsalertsforadversetransfusionreaction,lowstocklevels
and expiring units of blood.

30

ProcessDriven:Havingbeenbuiltwithinputsfromdomainexpertsofthebloodtransfusionin
dustry,thesoftwarehascoveredthevariousstagesofbloodbankinginacomprehensivemann
er.Itcoversredcellantigen,plateletantigenandHLAtyping.Ittakesintoaccountinformedco
nsentofdonorsdependingonthetypeofcollection(wholebloodoraphaeresis),exhaustivein
formationrelatedtobloodcollection,donorreactionsaswellasvariousstagesofthecompon
entmanufacturingprocessdependingonthekindofbagused.Theseprocessdrivenstagesca
nbetracedperbloodunitandtechnicianscanalsogenerateworklistscorrespondingtotheses
tagesthattheychoosetodoinbatches.

EnhancedTraceability:acuVenacoversallthestagesofdonormanagementandcomponentpreparation.Th
ebloodbankpersonnelusingacuVenacantracebackanybloodunittothedonormedicalhist
oryortothedateofpurchaseofthebloodbagfromthevendor.Theintelligentlabelingsystem
alsodisplaysthetestresultsoftheTransfusionTransmittableInfectiousmarkerscarriedouto
nthebloodunitforenhancedsafety.Anyadversetransfusionreactioncanbedocumentedint
hesystemandisonceagaintraceabletothedonorand bloodbag.

GreaterCompliance:Thesystemgeneratesmostoftheessentialreportsrequire
dtobesubmittedtotheauthorities.Manybloodbankseitherdedicatepersonnel
forthisactivityorspendalotoftimecollatingthisdataagainasmostoftheproces
sesandconsumablesofthebloodbankarenotfedintothebloodbankmoduleofth
eHIS.acuVenasprocessdrivenapproachnotonlycapturestheessentialinforma
tion,itgeneratesmost
ofthereportsrequiredbytheauthoritieswhoseekthisinformation.Theserepor
tscanbegeneratedinadditiontothemanualregistersbeingmaintainedbythebl
oodbank.

FocusonPointofCare:DeployingabestofbreedbloodbanksoftwarelikeacuVenaensur
esthatseniorofficialsconcentrateonusingthedataeffectivelytoachievetheirqualityin
itiativesratherthancreatingthereports.Byfreeinguptheirtimefromreportgenerating
activity,italsoenablesthecareprovidersinabloodbankfocusmoretransfusioncareandresearchrelatedactivities.

31

NovartisIndiaLimited
Thematic Areas
Healthcare
Location of Arogya Parivar sites
Uttar Pradesh, Uttaranchal, Bihar, Rajasthan, Gujarat, Maharashtra, Chhattisgarh, Andhra Pradesh,
TamilNadu, Karnataka

Case Study:Arogya Parivar Improving healthcare access for Indias rural poor
Mission:Toimprovehealthcareaccessfortheunderservedmillionslocatedatthebottom-of-the-pyramidusing
social business approach.

Objective:To create health awareness among people and toimprove healthcare infrastructure for
themarginalized rural poor.
Reaching out to rural India
AccordingtotheWorldHealthOrganisation,65%ofIndia'spopulationdoesnothaveaccesstoqualityhealthcare.The
senot-soprivilegedpeoplearedisfranchisedoftheirrighttohealthwithwomenandchildrenbeingamongtheworstsufferersint
he600,000
+
villages
spread
across
the
country.
Low
diseaseawareness,poorhealthcareinfrastructure,lowincome(50%liveonlessthanadollaraday),lackofanadequa
tedistributionsystemexacerbatestheissue.Fordailywageearners,goodhealthisoftennotapriority.
Novartisfirmlybelievesthatpharmaceuticalcompaniescanplayanimpactfulroleincreatinghealthcareawarenessa
mongthepoorandalsoinupgradingtheknowledgeofhealthcareproviders.Towardsthisend, Novartis set up
Arogya Parivar, a rural healthcare initiative, as a pilot in two states in 1997.
ArogyaParivarisbasedonthefourpillarsofawareness,adaptability,availabilityandaffordability.Theseprinciplesw
orkinanintegratedwaytoensurelong-termimpact,andmakecomprehensivehealthcareavailable in rural areas.
Themedicinesincludeanti-TBdrugs,antibiotics,anti-infectives,anti-diabetics,brandedgenerics,over-thecountercuresforcoughs,colds,allergies,diarrheaandcalciumdeficiencies.Productsalsoincludenonsteroidalanti-inflammatoryagents,anti-fungalandantianxietytreatments.Itcombinessocialentrepreneurshipwithcorporatesocialresponsibilitytospecificallyaddressth
ehealthneedsofruralIndiawhileprovidingopportunitiestoexpandbusiness in an innovative and responsible
way.
Itemploysacombinationoftechniquesusedbypharmaceuticalandconsumergoodscompaniesanditsfundamenta
linnovationrestsonapplyingamarketingmixbasedonthe4AsAwareness,Acceptability,Affordability
and
Availability adapted to low-income markets.
Awareness:ArogyaParivarconductshealtheducationprogrammesatthegrassrootslevelwiththehelpofHealthEd
ucatorsrecruitedfromamongthevillagersthemselves.Educatorsshareinformationonpreventive
health
measures and educate the community on the need for and importance of good health.
Adaptability:Thetherapeuticareaportfolioiscustomisedasperthelocaldiseaseburden.Allcommunicationincludi
ngthatonproductpacks is adapted to local conditions.

32

Availability:Stronglinkswithdoctorsensurelastmileavailabilityandgofarbeyondtraditionalpharmapracticeswhichfocusondoctordetailing.Theextendedsupplyc
hainreachesouttothelocalpharmacyinthe village.
Affordability:Innovativesolutions,strongbrandingandlocalresourcesmakea
difference.Sincevillagersoftenperceivemedicalcareasbeingexpensiveandinaccessible,medicinesaremadeav
ailablein small packs at affordable prices.
ArogyaParivarisorganizedaroundalightcentralmarketingandplanningteamresponsibleforcreatingmaterialsuse
dinthefield:leaflets,posters,trainingmanuals,minimoviesforawareness,includingtranslationinlocallanguages.It
goesbeyondsimplepromotiontothedoctortocreatingawarenessamong the rural population and finally
reaching out to every patient for drug compliance.
Fieldoperationsarestructuredintoindependentcells,eachcoveringaradiusofapproximately35kmor20miles.Eac
hcellismanagedbyasupervisor,assistedbyafewhealtheducatorswhosemainroleistoraisediseaseawarenessam
ongthepeopleincludingpreventionandtreatment,referpatientstodoctors,brief physicians about the program
and meet patients to ensure patient completes prescribed treatment.

The patient at the centre


All activities are centred on the patient by involving various stakeholders.
1.

Complement doctor detailing with FMCG marketing approach resulting in a new way to market
2.

3.

IntroducenewpacksizessopricepointremainssameasalsoproductssuchasORS(oralrehydration salts)
aimed at the rural market.
Distribution system uses foot soldiers so that itreaches critical economic mass for direct deliveries.
4.
5.

Collaborativeeffortwithlocalsocialdevelopmentagenciesforcommunityparticipationandwiderreach.
Followsapatientcentricapproachthataddressesthecommunityonhealthissues,educatesandmotivatespe
oplefortheiroverallwellbeing,usesdoctorreferralcardstohelptrackpatientsandengageswiththepatienttoensurecompliance.

Reaping results
ArogyaParivarhasenhancedaccesstomedicinesforcloseto50millionpeoplein10Indianstatescovering30,000+vi
llageswith11healthprograms:tuberculosis,skinandgynaecologicalinfections,diabetes,micronutrientsduringpregnancyandchildhood,intestinalworms,acidreflux,coughandcoldand
allergies.
People
covered is expected touch100 million (25% of people at stake) by 2011.
In2010,therewere250+Arogyacellscovering189districtsacross10statesinIndia,includingUttarPradesh,Uttaran
chal,Bihar,Rajasthan,Gujarat,Maharashtra,Chhattisgarh,AndhraPradesh,TamilNaduand Karnataka offering
improved healthcare access to almost 50 million people.
With11therapeuticapplicationstoaddresstherural/localdiseaseburden,NovartisinIndiahascomeupwithspeciald
rugsandpackagingtomeettheneedsofthisgrowingmarket.Forinstance,thecompanyhasdevelopedaWHOapprovedORS+Zincantidiarrhealformulationinaffordablesachets,andananiseflavor.TheArogyaParivarconceptisawinningone,empowe
ringvillagers,providingemployment,improvingruralhealthcare,andstrengtheningtheNovartisbrandintheremote
stofvillages.Whatmakesitextra special is that the model can be replicated inother geographies facing similar
healthcare challenges.

Arogya Parivar receives accolades


ArogyaParivarhasreceivedinternalandexternalrecognition.ArogyaParivarwasawarded"BestLongtermRuralMarketingInitiative"inIndiafor20062008byRuralMarketingAssociationofIndia(RMAI),largestassociationofitskindinthecountry.MorerecentlyArogy
aParivarreceivedtheCMOAsiaawardin
2010
for
the
best
rural
brand.The
initiative
alsoreceivedglobalrecognitionfromCorpEthicalin2010.

33

Chroni CareFoundation
An initi tivetowardspreventing chronicdiseases in India
Thesecondhalfofthetwentiethcenturywitnessedmaj

rhealthtransitionsintheworld,propelledby

socio-economicandtechnologicalchangeswhichprofoundlyalteredwaysofliving.Amongthesehealth
transitions,themostgloballyp
diseases(NCCDs).Ev

rvasivechangehasbeentherisingburdenofnon-communicablechronic

nasinfectio

sandnutritionaldeficienciesarerec

deathanddisability,cardiovasculardiseases(CVDs),cancers,diabete

dingasleadingcontributorsto
,nephrologicailments,andother

chronicdiseasesarebecomingmajorcontributorstotheburdenofdisease.Indiatooillustratesthishealthtransition,
whichpositionsNCCDsasamajorpublichealthchallengeofgrowingmagnitudeinthetwenty-firstcentury.
TheWorldHealthReport2001hadindicatedthatNCCDsaccountforalmost60%ofdeathsand46%of
theglobalburdenofdiseases.Seventy-fivepercentofthetotaldeathsduetoNCDsoccuri

developing

countries.Faci gadoubleburden,withaheavyloadofinfectiousdiseasesandanincreasingb
toNCDs,itis

etimated

that India accounts for17%of

globalcardiovascular

rdendue

mortality, and thisis

projected torise to 50%in the future, therebyaccountingfor a majorproportion ofdisease and deaths.
With a visionto

promote good healthby

proactively

minimizingtheincidenceandeffectsofchronicdiseasesin
theIndia,ChronicCareFoundation(CCF)wasset

pasa

notforprofit foundation, n 2006,toaddressissuesrelating


tochronicdiseases.CCFworkstopromotegoodhealthby
proactivelymini izingtheincidenceandeffectsofchronic
diseaseinsocietyandseekstoempowerthecommunitythroughpreven
tion,advocacy,educationandcollaboration
amongst stakeholders and the community leadingto
accessible,efficienthealthcaresystemthatimprovesthesafety
andqualityofcareofpatientswithchroniclifestylediseases.Thef
oundationiscommittedtowardsimproving
thecareandoutcomeofpatientswithnoncommunicablechronicdiseaseslikecardiovasculardiseases,diabetesan
d chronickidneydiseases.
The foundations activitiesrange from conducting studiesto identify the cause ofthee
diseasesto
developingprogramsforpromotinghealthybehaviourandworkingwithmedicalpractitionersforbetter
deliver

andoutcomes.TheorganizationhasundertakennicheresearchtitledNCCDsinIndiaA
studyofthegaps,qualityandcostofcareonnon-communicablechronicdiseasesonapan-India
basis-studyin17statesofIndia.Majorrecommendationsthate
ergedfromtheresearchhighlightthat
community based activities incl ding education,communication,

and interventions incommunities,

schools,andworkplacesareessentialtoprimarypreventionofNCCDs.Recommendationsalsoinclude
theneedtoimprovesecondaryandpreventionofNCCscree
ning;and accessible tertiarycare.

sbymeansofimprovedheathcarefacilitiesand

Under the National Programme for Preventionof Non


Communicable Chronic Disease, CCF has launcheda
National Health Campaign titled Swast Log,Swasth
h
Deshtospreadawarenessontheriskfactorsleadingtochronicdis
easeswithspecificfocusontobaccoandalcohol

in17

tates ofIndiain

collaboration with NGOs, private

sector partners and government bodies.It


population of600,000

coversa

including schools (n=22), women

34

groups(N=32),villages(51)andurbanslums(17)in17statesofIndia.CCFhasorganizedseveral
capacitybuildingworkshopsforparnerNGOstoworkonhealthpromotionprogram

eandcreateda

trained team of street theatre groupsand magiciansforcommunitylevel awareness generationactivities.


CCF also develops and disseminates communication material and
strategies to promote positive behaviour amongst individuals,
communitiesandsocietiesforpreventionofNCDsandhelptoprovideasupport
iveenvironmentforthepeopletosustainpositivebehaviour.We
have launched health campaigns, Health
elas and developed
BCC/IEC materialspiloted inPunjab, Haryana, Delhiand UttarPradesh.
Chronic Care Foundation has also organized regional Round Table
ConferencesofSpecialistsonNonCommunicableChronicDiseasesin
four regions

ofIndia

withan

aimto

emerge

with

regional

recommendationsforinterventionsbydifferent stakeholders.
Withchanginglifestylepatterns,tobaccoisemergingasthe
leadingc useofdeathanddisabilityworldwide.Addressing
thedireconsequencesontobaccouseonhealth,CCFhas
conducted several awareness generation programmeson
tobaccoasariskfactorforchronicdiseaseincoordination
withitspartnerNGOsin

chools,slums,generalcommunity

levelprogrammeinResidentWelfareAssociations.Oneof
the campains

was organizedin

entitledNashaMukhtP
diShaan).

Amritsarin

Jan 2010

njab(PunjabdajoshPunjab

The campaign ws directedat

the youthto

channelizethemintoeffectivechangeagentsofhealth.Overaperio
dof5days,15streetplayswerestagedacrossthe
cityofAmritsar-includingmarketplaces,malls,schoolsandcolleges,sensitizingthelocalcommunityonthe illeffect
of addictions(tobacco, alcohol and drug)on health.
CCFinpartnershipwit

AnchalCharitableTrustandPfizerIndiahaslaunchedapilotinitiativeonPublic

privatepeoplepartnershipfortobaccocontrolinPahariBastiandHauzKhasareaofSouthDelhi.Theprojectaimstode
velopaholisticapproachtowardsprevention,treatmentandcarefortobaccousers.
HealthCamps(inPahariBastislum)
ndHealthTalks(inResidentWelfareAssociations,HauzKhas)
havebeenorganisedtoprovideinformationontobaccocessation,psychosocialcounselingandsupportavailablefor
quitting.CCFhassuccessfullyestablishedlinkageswithinstitutionslikeRMLHospitalandDentaldepartmentofAIIM
Sforcounselingandreferraloftobaccouserswillingtoquit.CCFhasalso
established linkages with indivi ual RWA,
federation ofRWA

and private doctors inHauz

Khasarea forreferral of to acco users.

35

FreseniusMedicalCareIndia
Thematic Area
Critical Care Affordable Quality Dialysis Treatment for HIV Patients
Case
StudyIntroduction
HIVinfectionorAIDsahealthcatastrophefirstreportedinIndiain1986inthestateofTamilNaduhasspreadacrossthev
ariousstatesofthecountry.India,ifseendemographically,maintainsastatusofsecondlargestcountryisunfortunatel
yalsothirdlargestcountryintermsofPeoplelivingwithHIV/AIDS(PLHAs).
AsperNACOreportprevalencerateofHIV/AIDSinIndiais0.29percent(200809)amountingthetotalpopulationofmorethan2.27millionpeople.Thesituationismoredauntingasnearly89%ofPL
HAscomefromotherwisehighlyproductiveagegroupof1549yearsmakingtheeconomicimpactgraver.MoreoverwithasocietylikeIndiawherestillmajorityoffamilybreadearn
eraremen,outoftotalinfectedpopulationapproximately60%happenstobemale.Althoughwiththeconcentratedeff
ortofNACOandotherorganizations,scenarionowisfarbetterthanitusedtobeinyear2002withaprevalencerateof.4
5percent of countrys population.
TimeisnowtoextendthesupporttoHIV/AIDSpatientsbeyondART,HAARTandPARTandalsofocusingavailabilityof
treatmenttothediseasesthatthispopulationisthusexposedto.ThecaseinfocusshowcasesgrowingnumberofHIV/
AIDSpatientsalsobecomingendstagerenaldisease(ESRD)patients,therebytheirgrowingdemandofdialysistreat
mentandinsufficientsupplyofqualitydialysistreatmentandhowaninitiativebyFreseniusMedicalCarealongwithTA
NKERfoundationhasmadeanimpact.
Requirement of Dialysis Treatment for Positive Patients
Asperstudiesalmost17percentofPLHAssufferfromChronicKidneyDisease(CKD)sometimeortheotherandalmo
st0.5to1%ofthemendupsufferingfromESRDtakingthefiguretoaround3,000(estimated)patients.Withmaximumh
ospitalsandtreatmentfacilitiesrefusingdialysistoHIV/AIDSpatientsthedemandandsupplygapisveryhighandresu
ltinginhighermortality.
Initiative by FMC India and TANKER Foundation
Astheysayproblemsarethebiggestopportunities,theissuesfacedbypatientsweretriggerforthejointinitiativeofFM
CIndiaandTANKERfoundation.MajorissuewasthatHIV/AIDSinfectedpatientswerebeingdeniedDialysistreatme
ntinprivatehospitalsandthegovernmentfacilitiestoowerenotfullyequippedforthetreatmentdelivery.Realizingthe
demandsupplydisparityandwithavisionofprovidingaffordablequalitydialysistothismuchneededsegment,FMCIn
diaandoneofitscloseassociates,dedicatedtowardsprovidingrenalcareandlowcostqualitydialysis,TANKERFoun
dationjoinedhandsand started a dedicated facility for patients suffering with HIV/AIDS in Chennai.
Thefacility,inauguratedbyMr.VayalarRavi,Unionministerofoverseasaffairs&civilaviation,inauguratedthefacility.
ThefacilitystartedwithtwoHIV/AIDSpatientsandtodayprovidestreatmenttomorethan6patients.Thisparticularfac
ilityofTANKERfoundationtodayhasbecomeonlyfacilityprovidingqualitydialysistreatmentataffordablecosttoHIV/
AIDSpatients.Moreoverthereisnodiscrimination done in treatment fees between HIV/AIDS patients and
other patients.

36

Treatment Package
PatientsbeingtreatedatTANKERFoundationdialysisfacilityarechargedRs.375perdialysistreatmentwhichisalm
osteighttimeslessthanwhatisgenerallychargedbyotherhospitalsfromHIV/AIDSpatientsforsimilartreatment,ifata
lltheyprovideso.ThemedicinesupplyistakencarebyTamilNaduAidsControlSociety.Thenominalcostchargedfort
hetreatmentincludeschargesforalltheaccessoriesusedindialysisandothermedicineslikeerythropoietininjection
s,ironsourceinjectionsandantihypertensivedrugs.
Impact of Initiative

The dedicated facility has become only center


providinglowcostqualitydialysistoHIV/AIDSpatients.

The facility is seen as single referral center for dialysis for HIV/AIDS patients in Chennai city.

Thereis a significantimprovementinthelifestyle and confidence levels of patients being


treatedinthefacility.

With high quality standards in place till date thereisnorecordedinfectiontodoctorsortheclinicalstaff


treating the patients, reinstating the fact that providing qualitydialysis to HIV/AIDS patients
istotallysafefortreatingpractitioners.

Observations

It the qualityand hygiene standards are maintained properly then there is no excess risk
ofinfections from HIV/AIDS patients to the treating doctors and clinical staff.

With increasing life expectancy of HIV/AIDS patients, after introduction of HAART and
ART,demand for dialysis treatment from the segment has increased and in future is bound to
furtherincrease.

With world class qualitystandards in place, positive as well as normal patients can be
provideddialysis treatment on the same machine.

There is a social stigma and fear in dialysis patients of getting infected if they are being treated
onsame on which a dialysis patient is being treated. And a zero tolerance level for this.

Great amount of awareness & education work isrequired for general public in general and
dialysispatients in specific that if quality standards are followed HIV+ as well as a normal ESRD
patientcan be treated on the same machine.

If a clinicismaintaininghighqualitystandards,ideallyasrecommendedbyCenterforDiseaseControl
(CDC, USA) then there is no requirement of routine screening for HIV positivity in dialysispatients.

Confidentialityofthepatientsclinicalconditionshallbemaintainedveryspecifically.

Patients infected with HIV/AIDS can be dialyzed by either Hemo-dialysis or Peritoneal dialysis
asnormal patients.

There is no need for positive patients to be isolatedfrom other patients, as this creates
socialinhibition.

Single use of dialyzer is always recommended but with proper dialyzer reprocessing
anddisinfecting procedures in place clinics
mayincludeHIV/AIDSpatientsinthedialyzerreuseprogram.

With the success of the initiative the foundation looks ahead to spread the treatment and care
facilitiesacross the state.

37

ShanthaBiotechnics
ThegenesisofShanthaBiotechnicsLtdcanbetracedbacktotheinitiativesofDr.KIVaraprasadReddy,theFoundera
ndManagingDirector.Dr.Varaprasad,anelectronicsengineerbyprofession,establishedthecompanyin1993witha
missionstatementTodevelop,produceandmarketcost-effectivehumanhealthcare products that conform to
internationalstandardsofhighorder.
ShanthaBiotechnics,AnISO9001certifiedcompany,hasdevelopedandcommercializedIndiasfirstrecombinantH
epatitisBvaccinefollowedbyhumaninterferonalpha,Erythropoietin,choleravaccine,measlesvaccinebesidesTetravalent
vaccine(DPT+Hepatitis-B)andPentavalentvaccine((DPT
+Hepatitis-B+Hib).IthappenstobeWHO-Genevapre-qualifiedsupplierofHepatitis-Bvaccineandcombination
vaccines.
TheseedsofthisambitiousventureweresowninGenevaataconferenceonglobalprogramsforimmunization.Thisis
whereVaraprasadfirstrealizedthepressingneedforanaffordableHepatitisBvaccineforIndia.Atthatpointintime5%ofIndianpopulation(45million)wasHepatitisBviruscarriers.ButthevaccineisnotyetincludedinIndiasNationalImmunizationProgramnotwithstandingWHOsd
irectiveduetothepricefactor.Theimportedvaccinewasverycostlyandunaffordableeventouppermiddleincomegroups.Indigenousvaccineswerenotavailable.InthosecircumstancesShanthaBiotechnics took birth.
Buyingtechnologyfromabroadwouldhavepushedupthecostoftheproduct.Sotomakethevaccineaffordabletoco
mmonman,Varaprasaddecidedtodevelopthetechnologyinhouseratherthanimportingitatahighercost.HisearlyyearsinR&DaselectronicsengineerinDefenseElectronicsLa
bs,hadgivenhimconfidenceinIndianScientifictalentandhewasconvincedthatwecouldputIndiaonthemapforGen
eticEngineering,ifproperatmospherewasprovided.Thusheunwittinglyheraldedbiotechrevolutionin India.
Thejourneywasnoteasy.FundingwasmajorhurdleasbiotechwasunheardofinIndiathosedays.Thankstoinvestors
fromOmanandTechnologyDevelopmentBoardinMinistryofScience&Technology,ShanvacB,firsteverindigenouslydevelopedHepatitisBvaccinecouldseethelightofthedayinAugust1997.ByadoptingnovelmarketingtechniqueslikeMassVaccination
Campstoreachtheconsumer,Shanthacouldcutdownsupplychainexpenses.Also,itcreatedmuchneededawaren
essoftheimportance of Hepatitis-B eradication among masses.
EvenwhilesellingShanvacth

Bvaccineat1/10 ofthecostofimportedvaccine,theymaintainedinternationalstandardsintermsofqualityandtorea
chthebenchmark,successfullygonethroughWHOprequalificationformostoftheirproducts.WhenPfizeraskedthemtoproduceHepBvaccineundertheirbrandname,theassociationhelpedShanthatoperfectsystems,proceduresanddocumentatio
napartfrom bettering quality of the product.
ShanvacBbecameoneofthefastestgrowingbrandsintheIndianpharmaindustry,anditssuccessattractedfournewIndianco
mpaniestolaunchtheircompetingHepatitis-Bdrug.GSKsshareinIndiaforHepatitisBfellfrom100%in1997tojust10%in2000.Over1998-2000,Varaprasadreceived47awards.ThisincludedthefirsteverNationalTechnologyawardreceivedfromthePrimeMinisterinMay1999forhomegrowntechnologies.In2000,Ernst&YoungbestowedEntrepreneuroftheYearAwardonhimforhiscontributionstoth
efieldoflife-sciences.
VaraprasadwasawardedPadmabhushanin2005andVaraprasadandShanthatogetherwonmorethan250award
sbynow.Withoutrestingonlaurels,theypursuedtheirpathvigorouslyandcarvedanicheforthemselvestoattractthea
ttentionofinternationalPharma majors.
Shanthareinvests25%ofrevenuesbackintoR&D
thehighestofanycompanyinthecountry.InIndia,R&Daveragewasonly0.1to0.2%,andintheUS,mostmajorcompa
niesputonly4to5percentinto

38

R&D.TheresearcheffortsatShanthaarefurtherstrengthenedbycollaborativearrangementsandallianceswithlead
ingresearchinstitutionsinIndiaandabroad.Currently,ShanthaBiotechnicsisfocusingits R&D efforts in the
development of vaccines only.
ShanthacaterstomajorinternationalmarketsincludingAsiaPacific,Africa,CISandLatinAmericainadditiontosupranationslikeUNICEFandPAHO.Itexpandeditsvaccinesport
foliobylaunchingcombinationvaccinesandnewgenerationvaccinesproducedindigenouslyatitsWHOcGMPplant
nearHyderabad.
ApartfromthesingledoseHepatitisvaccineShanthaBiotechnicsisworkingontyphoidconjugate,acellularpertussis
andcomplaintbasedDPT.Rotavirusvaccinewillalsobeanimportantpartofthecompany'sportfolio,apartfromHuma
nPappilomaVirus(HPV).AmongtheotherproductsinthepipelineareJEvaccines,vaccineforvaricellazosterandheat-stablevaccines.
th

InSeptember2009,Franceslargestandworlds4 pharmamajor,SanofiAventis,hadacquiredan80%stakethatanotherFrenchfamilybusinessMerieuxAllianceheldinShanthaBio.
SanofireaffirmeditscommitmenttoVaraprasadspublichealthmissionofprovidingaffordabledrugs.Itplannedtode
velopShanthaBiointo a globalR&Dhub,andtoexpand in India and in other emerging markets.
LegendarySanofiPasteuristhevaccinecompanywithmorethanacenturyoldexperienceindevelopment,productionandmarketingofvaccines.ShanthasworldclassmanufacturingfacilitiescomplyingwithUSFDAstandardscanbebestoptimallyutilizedbySanofiPasteurform
eetingglobalvaccinedemand.ShanthacanbecometheextendedplatformofSanofiPasteurinSouthernhemispher
eto serve the global vaccine requirements.
OneofShanthaspremiumproducts,Pentavalent(HepB+DPT+Hib)vaccinecanbecombinedwithSanofisIPVvaccinetocomeoutwithHexavalentvaccine.Suchmanym
orewinningcombinationscanemergetoservethehumanity.TheproductportfoliosofSanofiandShanthaarecomple
mentarytoeachotherandtheirworkingtogetherwillmaximizebenefitsofvaccination.Thiscutsdownthecostofdevel
opmentofvaccinesandtheultimatebeneficiaryisthecommonmanindevelopedaswellasdevelopingnations.

39

GoingGlobal-theIndianMNC
VLCCHealthCareLimited
Date of registration of the company- 23/ 10/
1996Date of Commencement of Business- 23/ 10/
1996
Mission: TransformingLives
Impact:VLCChashelpedimproveIndiaswellnessquotient,helpingmillionsmakethetransitiontohealthy lifestyles
Legacy: Undisputed pioneers
TheVLCCsuccessstorystemsfromitsunwaveringbrandcommitmenttotheideaofTransformingLives

thegroupsguidingvision.TheVLCCtransformationcentersseamlesslymarriedthescientificslimmingprogramswi
thcuttingedgeskinandhairtreatments.VLCCcontinuestopursuethemissionwithitsnetwork spread over 225
centers across 100 cities in 8 countries.
VLCCsfounderandmentor,VandanaLuthraopenedIndiasfirstTransformationCentreinNewDelhiin1989,atatim
ewhentheIndianmarketforwellnesssolutionswasstillnascent,andtheconceptofcombiningfitnessandbeautyasa
napproachtoholisticwellness,asinitiatedbyher,wasacompletelynew paradigm.
Today,VLCCisapioneerintheglobalwellnessarenawithpresenceinthreerelatedbusinessesinthewellness
domain:
- Slimming, skin & hair services;
- Education&traininginstitutes;
- Manufacturing&retailingofpersonalcareproducts.
VLCCcentersareopen7daysaweek,andserviceover75,000customervisitseverymonth.Inaworldruledbychangi
nglifestylesandinstantremedieslikecrashdietsandappetitesuppressants,theUSPoftheVLCCweightmanageme
ntprogramhasalwaysbeentheirholisticandscientificapproachtowardstransformation.Theirslimmingprogramsar
ebasedonscientificprinciples,usinglifestyleanddietarymodifications,anddonotinvolveanysurgicalproceduresor
crashdiets,nordotheyrequireconsuminganymedication,dietpillsorhungersuppressants.VLCCsslimmingbusin
esshelpstheearthbecomelighter by over 90,000 kgs every month.
VLCC International
Theyear2006markedVLCCsforayintooverseasmarkets,withtheopeningofitsfirstcentreinDubai.VLCC'smajorfo
cusistotacklethescourgeofobesityanditmadeeminentsensetolookattheMiddleEastmarketasitsfirstoverseasfor
ay,giventhatobesityintheMiddleEastisratedasbeingamongstthehighest in the world. In UAE specifically, over
60 percentofthepopulationiseitheroverweightorobese.
Today,VLCCisaninternationalbrandwithpresencespreadover16centersintheinternationalmarketwith10centers
intheUAE,twoeachinOmanandBahrainandoneeachinQatarandNepal.TwoVLCCcentersinSriLankaandoneinB
angladeshwillbeoperationalbyMarch2011.Bytheyear2012,VLCCexpects to expand its presence to 28
locations across the MENA and SAARC countries.

40

Largest Organised Player


TheVLCCservicesbusinesshasaretailfootprintofamillionsquarefeetofretailspaceacrossthecountry
fromJammuinthenorthtoTrivandruminthesouthandfromShillongintheeasttoSuratinthewest,apartfromitspresen
ceintheMiddleEast.VLCCisnowwellrepresentedacrossthecountry,with34locationsinsouthIndiaalone.Regiona
lbusinessheadsandofficesenablepromptandefficientservicedelivery.
VLCCPersonalCarehasmanufacturingfacilitiesinDehradunandHaridwar.Itscurrentdistributionnetworkcoverso
ver20,000retailersand300distributorsinIndia,Nepal,SriLankaandtheGCC.This business network is being
expanded continuouslytokeeppacewiththedemand.
TheVLCCGroupcurrentlyhasover3000directemployeesincludingover700inoverseasoperations,andnearly400
0indirectemployeesfrom29nationalities,withmajorityofthesebeingdoctors,nutritionists,
psychologists,
cosmetologists, physiotherapists and the like
Interwoven Social Responsibility
AtVLCC,CorporateSocialResponsibilityisdefinedaroundtwodimensions
oneisthemissiontoeradicateobesityandspreadawarenessaboutobesity,diseaseslinkedtoit,anditslifestylerelate
dcauses.TheotherdimensionofitsCSRinitiativesfocusesoncreatingopportunitiestosupporttheunderprivilegeds
ectionsofoursociety,workingtoalleviatepoverty,andinparticularfortheempowermentof women.
Somekeyhighlights:

VLCC centers offer slimming, skin and hair care services

Over 225 centers spread across the globe

VLCC makes the earth lighter by 95,000 kilos (weight loss) ever year

More than 10,00,000 satisfied customers served since inception

Allcentersarecompanyownedandmanagedwiththeexceptionof35franchiseesinTierIIandTier III cities


in India.

Businesses:
o VLCCSlimming,Skin&HairServicesCentersofferweight-losssolutions,beautytreatmentsandregular
beauty salon services.
o VLCCInstitutesofBeauty&Nutritionofferprogramsinbeautyandnutrition.Withapresencespreadacross4
9campusesin38citiesinIndia,itistodayAsiaslargestvocationaltrainingnetwork of its kind.
o VLCCPersonalCareisaproprietarylineofover100herbalandayurvedicskin-care,hair-careandbodycareproducts.TheseproductsareavailableatallVLCCcentresandarealsoretailedthrough20,000plussto
resacrossIndiaandoverseas.SHAPEUP,itsflagshiplineofbodyshaping products is a category leader.
o TheVLCCDaySpasinMumbai,Delhi,KolkataandGurgaon,aluxuryofferingfromthehouseofVLCC,offers
patherapiesfromaroundtheworldasalsoadvancedhair,skinandnailservices.Theservicesatthespaareac
ombinationofthetime-honoredtraditionofpersonaltouchwiththelatest skin care equipment and spa
technology for "results-oriented" treatments.
o TheVLCCNutriDietClinicprovidescustomizedsolutionstoaddressesdietneedsfromnormaltomedical/th
erapeuticconditions,helpingpeopleadoptholisticwellnessintheireverydaylives.Itisaimedatimprovingth
eoverallwellnessquotientofindividualsthroughadvisoryservicesfordietaryintake,customizedonthebasi
softheindividual'sspecificbio-chemicalparametersandlifestyle.

41

Acknowledgement
VLCCistheworldsfirstslimming,fitnessandbeautycorporatetogettheISO9001:2000andSA:800O(SocialAcco
untability)certificationforimplementingcorporatesocialresponsibilitystandards.TheVLCCGrouphasalsobeen
awardedtheISO:14001certificationformeetingglobalenvironmentstandards, again a worlds first for a
company in its line of business.

42

AboutKPMGinIndia
KPMGisaglobalnetworkofprofessionalfirmsprovidingAudit,TaxandAdvisoryservices.Weoperatein146countrie
sandhave140,000peopleworkinginmemberfirmsaroundtheworld.TheindependentmemberfirmsoftheKPMGne
tworkareaffiliatedwithKPMGInternationalCooperative(KPMGInternational),aSwissentity.EachKPMGfirmisal
egallydistinctandseparateentityanddescribesitselfas such.
OurAuditpracticeendeavorstoproviderobustandriskbasedauditservicesthataddressourclients'strategic
priorities and business processes.
KPMG'sTaxservicesaredesignedtoreflecttheuniqueneedsandobjectivesofeachclient,whetherwearedealingwit
hthetaxaspectsofacrossborderacquisitionordevelopingandhelpingtoimplementaglobaltransferpricingstrategy.Inpracticalterms,thatme
ansKPMGfirmsworkwiththeirclientstoassistthem in achieving effective tax compliance and managing tax
risks, while helping to control costs.
KPMGAdvisoryprofessionalsprovideadviceandassistancetoenablecompanies,intermediariesandpublicsector
bodiestomitigaterisk,improveperformance,andcreatevalue.KPMGfirmsprovideawiderangeofRiskAdvisoryand
FinancialAdvisoryServicesthatcanhelpclientsrespondtoimmediateneedsas well as put in place the strategies
for the longer term.
KPMGinIndia,aprofessionalservicesfirm,istheIndianmemberfirmofKPMGInternationalCooperative(KPMGInt
ernational.)wasestablishedinSeptember1993.Asmembersof
a
cohesivebusinessunittheyrespondtoaclientserviceenvironmentbyleveragingtheresourcesofaglobalnetworkoff
irms,providingdetailedknowledgeoflocallaws,regulations,marketsandcompetition.Weprovideservicestoover5,
000internationalandnationalclients,inIndia.KPMGhasofficesinIndiainMumbai,Delhi,Bangalore,Chennai,Hyde
rabad,Kolkata,Pune,KochiandChandigarh.ThefirmsinIndiahaveaccesstomorethan5,000Indianandexpatriate
professionals,manyofwhomareinternationallytrained.Westrivetoproviderapid,performance-based,industryfocusedandtechnologyenabledservices,whichreflectasharedknowledgeofglobalandlocalindustriesandourexp
erienceoftheIndianbusinessenvironment.

43

ASSOCHAM
THE KNOWLEDGE ARCHITECT OF CORPORATE INDIA
EVOLUTION OF VALUE CREATOR
ASSOCHAMinitiateditsendeavourofvaluecreationforIndianindustryin1920.Havinginitsfoldmorethan300Cham
bersandTradeAssociations,andservingmorethan350000membersfromalloverIndia.Ithaswitnessedupswingsa
swellasupheavalsofIndianEconomy,andcontributedsignificantlybyplaying a catalytic role in shaping up the
Trade, Commerce and Industrial environment.
Today,ASSOCHAMhasemergedasthefountainheadofKnowledgeforIndianindustry,whichisallsettoredefinethe
dynamicsofgrowthanddevelopmentinthetechnologydrivencyberageof'KnowledgeBased Economy'.
ASSOCHAMderivesitsstrengthfromitsPromoterChambersandotherIndustry/RegionalChambers/Association
s spread all over the world.
VISION
Empower
enterprise
by
inculcating
knowledge
that
willbethecatalystofgrowthinthebarrierlesstechnology driven global market and help them upscale,
align and emerge as formidable player inrespective business segments.
MISSION
As a representativeorganofCorporateIndia,ASSOCHAM articulates the genuine, legitimate needs
andinterests of its members. Its mission is to impact the policy and legislative environment so as to
fosterbalanced economic, industrial and social development.We believe education, IT, BT, Health,
CorporateSocial responsibility and environment to be the critical success factors.
MEMBERS - OUR STRENGTH
ASSOCHAM represents the interests of more than 350000 direct and indirect members. Through
itsheterogeneous membership, ASSOCHAM combines
theentrepreneurialspiritandbusinessacumenofowners with management skills and expertise of
professionals to set itself apart as a Chamber with adifference. Currently, ASSOCHAM has 90 Expert
Committees covering the entire gamut of economicactivities.Ithasbeenespeciallyacknowledgedas a
significant voice of the industry in the field ofInformationTechnology,Biotechnology,Telecom,Banking &
Finance, Company Law, Corporate Finance,Economic and International Affairs, Tourism, Civil Aviation,
Corporate Governance, Infrastructure, Energy
& Power, Education, Legal Reforms, Real Estate & Rural Development etc

44

ContactUs
VikramUtamsinghH
eadof
MarketsKPMGinIndia
T:+912230902320
E:vutamsingh@kpmg.com
VikramHosangady
HeadofHealthcareSectorKPMGi
nIndia
T:+9144 39145101
E:vhosangady@kpmg.com
AmitMookimDirect
or,AdvisoryKPMGinIn
dia
T:+91223090 2141
E:amookim@kpmg.com
JagrutiBhatia
AssociateDirector,AdvisoryKPMGi
nIndia
T:+91223090 2145
E:jagrutibhatia@kpmg.com
kpmg.com/in

Theinformationcontainedhereinisofageneralnatureandisnotintendedtoaddressthecircumstancesofanyparticularindividualore
ntity.Althoughweendeavortoprovideaccurateandtimelyinformation,therecanbenoguaranteethatsuchinformationisaccurateaso
fthedateitisreceivedorthatitwillcontinuetobeaccurateinthefuture.Nooneshouldactonsuchinformationwithoutappropriateprofes
sionaladviceafterathoroughexaminationoftheparticularsituation.
2011KPMG,anIndianPartnershipandamemberfirmoftheKPMGnetworkofindependentmemberfirmsaffiliatedwithKPMGI
nternationalCooperative(KPMGInternational),aSwissentity.Allrightsreserved.
TheKPMGname,logoandcuttingthroughcomplexityareregisteredtrademarksortrademarksofKPMGInternational.

Potrebbero piacerti anche